var data={"title":"Hepatotoxicity due to herbal medications and dietary supplements","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Hepatotoxicity due to herbal medications and dietary supplements</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/contributors\" class=\"contributor contributor_credentials\">Anne M Larson, MD, FACP, FAASLD, AGAF</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/contributors\" class=\"contributor contributor_credentials\">Sanjiv Chopra, MD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/contributors\" class=\"contributor contributor_credentials\">Kristen M Robson, MD, MBA, FACG</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Dec 21, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H2947492025\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Complementary and alternative medical (CAM) therapies are a diverse group of practices that includes the use of herbal and dietary supplements (HDS) (<a href=\"image.htm?imageKey=GAST%2F72867\" class=\"graphic graphic_table graphicRef72867 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/1\" class=\"abstract_t\">1</a>]. Between 1997 and 2002, overall CAM therapy use remained relative stable [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/1\" class=\"abstract_t\">1</a>]. By contrast, the use of HDS increased by 50 percent, from 23 million adult users to over 38 million adult users [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/1\" class=\"abstract_t\">1</a>]. The use of CAM therapies in the United States and worldwide has continued to increase dramatically [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/2\" class=\"abstract_t\">2</a>]. At least 55.2 million adults (23.5 percent) and 4.1 million children (7.1 percent) reported the use of CAM therapies, depending upon how they were defined, with out-of-pocket costs in 2012 exceeding $30.2 billion [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/3-5\" class=\"abstract_t\">3-5</a>]. The most commonly used CAM therapies were herbal and dietary supplements, with $12.8 billion of all out-of-pocket costs for the purchase of nonvitamin, nonmineral natural products [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/5,6\" class=\"abstract_t\">5,6</a>]. The most common reason for their use is for health improvement and health maintenance [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/7\" class=\"abstract_t\">7</a>]. Women and Alaska <span class=\"nowrap\">Natives/American</span> Indians were more likely to use CAM therapies, with greater use in persons younger than 65 years of age and in those with a higher annual household income [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/1,3,5,8,9\" class=\"abstract_t\">1,3,5,8,9</a>].</p><p>Use of herbal preparations can be traced back as far as ancient Egypt, China, India, and Sumeria, and formulations have been expanded upon over the centuries [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/10,11\" class=\"abstract_t\">10,11</a>]. Many patients consider &quot;natural&quot; herbal remedies to be completely free of unwanted side effects [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/12-14\" class=\"abstract_t\">12-14</a>]. This is concerning since many herbal products have biological activity that can lead to severe toxicity or that interact with each other or with prescription medications. Fewer than 40 percent of patients disclose to their clinician that they are using these products [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/1,3,15\" class=\"abstract_t\">1,3,15</a>].</p><p class=\"headingAnchor\" id=\"H2926900639\"><span class=\"h1\">DATABASE OF DRUGS, HERBS, AND SUPPLEMENTS ASSOCIATED WITH HEPATOTOXICITY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Over 1000 medications and herbal products have been implicated in the development of drug-induced liver injury, and the list continues to grow [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/16,17\" class=\"abstract_t\">16,17</a>]. A <a href=\"http://www.livertox.nih.gov/&amp;token=2zSk/UZTeO3J4oIM4h1Di9fg9utsfkFQlC3ryKItrySs0myBELRJEc3r1dIl6tjF&amp;TOPIC_ID=3618\" target=\"_blank\" class=\"external\">searchable database</a> of drugs, herbal medications, and dietary supplements associated with hepatotoxicity has been developed by the National Institutes of Health [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/18\" class=\"abstract_t\">18</a>].</p><p class=\"headingAnchor\" id=\"H122810330\"><span class=\"h1\">REGULATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In 1962, the Kefauver-Harris Drug Amendment required that all over-the-counter and prescription products show proof of safety and efficacy [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/19\" class=\"abstract_t\">19</a>]. Complementary and alternative medicines (CAMS) were assigned to the food supplement category and had a lower threshold of required evidence for safety [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/19\" class=\"abstract_t\">19</a>]. An attempt by the US Food and Drug Administration (FDA) in the early 1990s to develop more strict regulations was met with significant opposition by supplement manufacturers, lobbyists, and consumers.</p><p>The Dietary Supplement Health and Education Act (DSHEA) of 1994 was an amendment to the US Federal Food, Drug, and Cosmetic Act (FD&amp;C) [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/20\" class=\"abstract_t\">20</a>]. The DSHEA defined dietary supplements as products that are taken by mouth that contain an ingredient (vitamin, mineral, amino acids, enzyme, organ tissues, glandular, metabolites, and herb or botanicals) intended to supplement the diet [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/10,20-22\" class=\"abstract_t\">10,20-22</a>]. These products may be in the form of tablets, capsules, soft gels, gel caps, liquids, teas, or powders. The DSHEA named the United States Pharmacopeia&ndash;National Formulary (USP&ndash;NF) as its official reference for herbal preparations [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/20\" class=\"abstract_t\">20</a>]. The United States Pharmacopeia is an official public standards-setting authority for all prescription and over-the-counter medicines and other healthcare products manufactured or sold in the United States [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/23\" class=\"abstract_t\">23</a>]. The USP also sets standards for food ingredients and dietary supplements.</p><p>Under the DSHEA, the FDA is responsible for proving whether or not there are safety concerns and taking action against any unsafe dietary supplement product only after it reaches the market. Products that were already in distribution prior to 1994 were allowed to remain on the market; their use is often justified based upon experience from trial and error, not rigorous scientific scrutiny. Supplement manufacturers are not required to register themselves or their product with the FDA prior to distribution or to obtain FDA approval before producing or selling supplements [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/20,24\" class=\"abstract_t\">20,24</a>]. They are also responsible for reporting any side effect and ensuring that their product has not been adulterated [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/25\" class=\"abstract_t\">25</a>]. The FDA monitors product information, such as labeling and claims, and also monitors safety through a voluntary dietary supplement adverse event reporting system. Over the years, the FDA has issued several warnings on products that have been reported to have hepatotoxicity [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/26\" class=\"abstract_t\">26</a>]. The Federal Trade Commission regulates advertising of dietary supplements [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/24\" class=\"abstract_t\">24</a>].</p><p>The DSHEA requires that manufacturers establish product safety before marketing. Manufacturers must also ensure that the product label is truthful and not misleading. The label must contain a complete list all ingredients contained in the product and the identity of the manufacturer. Manufacturers must also limit the claims that can be made (health claims, nutrient content claims, and <span class=\"nowrap\">structure/function</span> claims) [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/27\" class=\"abstract_t\">27</a>]. <span class=\"nowrap\">Structure/function</span> claims are those which claim that the nutrient or dietary ingredient is intended to affect normal structure or function in humans (ie, &quot;calcium builds strong bones&quot;). They may also describe the means by which a nutrient or dietary ingredient acts to maintain such <span class=\"nowrap\">structure/function</span> (ie, &quot;fiber maintains bowel regularity&quot;), or they may describe general wellbeing from consumption of the nutrient or dietary ingredient. <span class=\"nowrap\">Structure/function</span> claims may also express a benefit related to a nutrient deficiency disease (ie, &quot;<a href=\"topic.htm?path=vitamin-c-ascorbic-acid-drug-information\" class=\"drug drug_general\">vitamin C</a> prevents scurvy&quot;). In this last setting, they must include a statement telling how widespread the disease is in the United States.</p><p>If a manufacturer makes a <span class=\"nowrap\">structure/function</span> claim on the supplement label, the DSHEA requires a disclaimer: &quot;This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.&quot;</p><p>The Final Rule for Current Good Manufacturing Practices for Dietary Supplements was passed in 2007 as a further step in attempting to ensure the safety of herbal and dietary supplements (HDS) [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/28\" class=\"abstract_t\">28</a>]. This rule requires that manufacturers follow certain standards in the production of HDS. Manufacturers are required to verify the contents of the product (ie, identify the ingredients, strength) and ensure that the product is contamination free. However, the Final Rule does not address the safety or efficacy of the product ingredient itself.</p><p>The DSHEA also requires that a product's label accurately reflect its contents. However, there may be significant discrepancies between the ingredients listed on the label and the actual contents of the preparation. This is especially true of preparations containing multiple plants or herbs (ie, Chinese remedies), which may be adulterated either unintentionally or intentionally by cheaper, more toxic herbs, heavy metals, microbials, and pharmaceutical medicines (such as <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a>, <a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a>, benzodiazepines, <a href=\"topic.htm?path=sildenafil-drug-information\" class=\"drug drug_general\">sildenafil</a>, or steroids) [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/12,13,29-44\" class=\"abstract_t\">12,13,29-44</a>]. As many as one-third or more of products can be adulterated [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/33,45-47\" class=\"abstract_t\">33,45-47</a>]. There can also be variations between batches of the same herbal product from the same manufacturer [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/29,48-50\" class=\"abstract_t\">29,48-50</a>]. It can be difficult to identify the agent actually responsible for the hepatotoxicity [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/51\" class=\"abstract_t\">51</a>].</p><p>The widespread use of mixed remedies and the lack of randomized trials make any review of the safety and efficacy of herbal remedies difficult. In addition, conformity to the USP standards is voluntary, and there are no regulatory standards for HDS.</p><p class=\"headingAnchor\" id=\"H2532524339\"><span class=\"h1\">FREQUENCY OF HEPATOTOXICITY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are no precise estimates of the frequency of hepatotoxicity attributable to herbal and dietary supplements (HDS). Patients often do not report the use of herbal products to their clinicians, and they self-medicate with large amounts [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/3,41\" class=\"abstract_t\">3,41</a>]. As a result, hepatotoxicity associated with herbal use may be missed. The United States Drug-Induced Liver Injury Network (DILIN) found that approximately 15 to 20 percent of cases of drug-induced liver injury (DILI) could be attributed to HDS [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/52\" class=\"abstract_t\">52</a>]. Additionally, this proportion of DILI cause by HDS increased from 7 to 20 percent between 2004 and2013 [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/52\" class=\"abstract_t\">52</a>]. Others, depending on the geographic location, have implicated HDS in up to 73 percent of cases of DILI [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/20,45,53,54\" class=\"abstract_t\">20,45,53,54</a>]. Additionally, it has been estimated that fewer than 1 percent of adverse reactions to dietary supplements are reported [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/20\" class=\"abstract_t\">20</a>].</p><p class=\"headingAnchor\" id=\"H3762083709\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients are often reluctant to discuss use of herbal and dietary supplements <span class=\"nowrap\">(HDS)/complementary</span> and alternative medicines (CAMs) or do not recognize them as &quot;medications&quot; [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/41\" class=\"abstract_t\">41</a>]. It is important for the clinician to discuss the use of these products with the patient in a nonjudgmental manner. Patients can then be educated on the potential adverse effects and herb-herb or drug-herb interactions that may occur. This may prevent the development of hepatotoxicity. However, the unreported use of herbal remedies must be considered as a possible etiology in any setting of clinical manifestations of liver injury. Liver injury may present as asymptomatic liver enzyme elevations, jaundice, hepatitis (nausea, vomiting, abdominal pain), and acute liver failure with coagulopathy and encephalopathy, or with signs and symptoms of cirrhosis. Frequently, nonspecific constitutional symptoms occur. </p><p>Continued use of the offending product greatly increases morbidity once hepatotoxicity has developed [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/30,55\" class=\"abstract_t\">30,55</a>]. The patient may even increase the use of the herbal preparation to help &quot;treat&quot; the new symptoms. As in other cases of elevated liver enzymes, all other causes of liver disease must be ruled out. Patients often use herbal remedies and concoctions to treat their chronic disease and may, in fact, exacerbate it [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/4,5,48\" class=\"abstract_t\">4,5,48</a>]. Continued ingestion of the herbal preparation in the face of ongoing hepatotoxicity may lead to acute liver failure or even cirrhosis [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/13,56,57\" class=\"abstract_t\">13,56,57</a>].</p><p>The pattern of liver injury is similar to that seen with other forms of drug-induced liver injury (DILI). It can be hepatocellular, cholestatic, a mixture of the two, or vascular (ie, sinusoidal obstruction syndrome). Hepatocellular injury appears to be more frequent with HDS than is seen with DILI secondary to conventional medications [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/26,57\" class=\"abstract_t\">26,57</a>]. In addition, those presenting with a hepatocellular pattern of injury have a poorer prognosis [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/58,59\" class=\"abstract_t\">58,59</a>]. (See <a href=\"topic.htm?path=drug-induced-liver-injury\" class=\"medical medical_review\">&quot;Drug-induced liver injury&quot;</a>.)</p><p>The diagnosis of liver injury secondary to HDS can be difficult. Clinical history may be helpful but is not always reliable. The relationship between the exposure and the hepatic toxicity is not always clear. In addition, patients may be taking multiple preparations, making identification of a single offending agent impossible. They may also have concomitant liver disease, such as alcoholism or nonalcoholic steatohepatitis (NASH), which can produce similar clinical and laboratory features. There is no gold standard and no specific tests or serum biomarkers to confirm a diagnosis of drug-induced liver injury from either a manufactured medication or an herbal remedy. Proving that an HDS causes liver injury relies on both chronological and clinical criteria [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/60,61\" class=\"abstract_t\">60,61</a>].</p><p>The Council for International Organizations of Medical Sciences (CIOMS) developed a series of standard designations of drug-induced liver disorders and classification of injury [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/62\" class=\"abstract_t\">62</a>]. The US Food and Drug Administration (FDA) Drug Hepatotoxicity Steering Committee proposed modifications to the CIOMS classification scheme for classifying hepatotoxicity in clinical trials (<a href=\"image.htm?imageKey=GAST%2F76892\" class=\"graphic graphic_table graphicRef76892 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/63,64\" class=\"abstract_t\">63,64</a>]. These guidelines are used as markers of hepatotoxicity in clinical trials.</p><p>A number of scales have been developed that attempt to codify causality of drug toxicity into objective criteria [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/65\" class=\"abstract_t\">65</a>]. The best known scale is the Roussel Uclaf Causality Assessment Method (RUCAM) scale, more recently called the Council for International Organizations of Medical Sciences (CIOMS) scale. Others include the Maria &amp; Victorino scale and a simpler clinical diagnostic scale (CDS) [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/61,66-68\" class=\"abstract_t\">61,66-68</a>]. Studies that have compared these models suggest that the RUCAM (CIOMS) scale may have better discriminative ability [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/60,65\" class=\"abstract_t\">60,65</a>]. While these scales have not been validated in the setting of herbal medications, they may be useful (<a href=\"image.htm?imageKey=GAST%2F55524\" class=\"graphic graphic_table graphicRef55524 \">table 3</a>). None of these scales address all risk factors in all patients, and none are used routinely in clinical practice [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/61\" class=\"abstract_t\">61</a>]. One of the most important diagnostic criteria remains the exclusion of other causes of liver injury. RUCAM (CIOMS) has been validated independently in the setting of drug rechallenge [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/67\" class=\"abstract_t\">67</a>]. The Drug-Induced Liver Injury Network (DILIN) developed the DILIN Causality Scoring System to adjudicate the causality of drug-induced injury for patients enrolled into its prospective clinical trial [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/69\" class=\"abstract_t\">69</a>]. This model relies on structured expert opinion, and when compared with the RUCAM, it produces higher agreement rates and likelihood scores. However, intraobserver variability remains significant. Unfortunately, the DILIN scale is not a clinically viable option of determining causality since it relies on expert opinion.</p><p>Features suggesting HDS hepatotoxicity include lack of illness prior to ingesting the HDS, clinical illness or biochemical abnormalities developing after beginning the offending agent, and improvement after the product is withdrawn. If an immunologic reaction is suspected, the illness will generally recur upon reintroduction of the offending substance. While it remains the gold standard for the diagnosis of drug-induced liver injury, rechallenge is not advised. Nonspecific symptoms developing after introduction of an HDS (such as nausea, anorexia, malaise, fatigue, right upper quadrant pain, or pruritus) may indicate HDS toxicity and should prompt evaluation. Unlike the more stereotypic presentations seen with hepatotoxicity due to most drugs, the clinical presentations of injury secondary to HDS are less typical and have been less well-defined [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/26\" class=\"abstract_t\">26</a>]. Exceptions to this are hepatotoxicity to anabolic steroids and pyrrolizidine alkaloid-containing products.</p><p>Key elements for attributing liver injury to an HDS are similar to those for other drug products and include [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/70\" class=\"abstract_t\">70</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Exposure must precede the onset of liver injury (although the latent period is highly variable).</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Underlying liver disease should be excluded.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Injury may improve when the HDS is stopped (although, in some cases, injury may initially worsen for days or weeks while, in fulminant cases, declining liver biochemical tests may indicate deterioration rather than improvement).</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Liver injury may have recurred more rapidly and severely after repeated exposure.</p><p/><p class=\"headingAnchor\" id=\"H734050788\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The mainstay of therapy for herbal hepatotoxicity is withdrawal of the offending toxin. Early recognition of toxicity is important to permit assessment of severity and monitoring for acute liver failure. (See <a href=\"topic.htm?path=acute-liver-failure-in-adults-etiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis&quot;</a>.) </p><p>Corticosteroids are of unproven benefit for most forms of drug hepatotoxicity, although they may have a role for treating patients with hypersensitivity reactions [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/71\" class=\"abstract_t\">71</a>]. Our practice is to give glucocorticoids to patients with hypersensitivity reactions who have progressive cholestasis despite herbal and dietary supplements (HDS) withdrawal and who have biopsy features that resemble those seen in autoimmune hepatitis. In addition, we give glucocorticoids to patients with extrahepatic manifestations of a hypersensitivity reaction that warrant steroid treatment (eg, severe pulmonary involvement in patients with DRESS [drug reaction with eosinophilia and systemic symptoms]). (See <a href=\"topic.htm?path=autoimmune-hepatitis-clinical-manifestations-and-diagnosis#H7\" class=\"medical medical_review\">&quot;Autoimmune hepatitis: Clinical manifestations and diagnosis&quot;, section on 'Histology'</a> and <a href=\"topic.htm?path=drug-reaction-with-eosinophilia-and-systemic-symptoms-dress#H97599699\" class=\"medical medical_review\">&quot;Drug reaction with eosinophilia and systemic symptoms (DRESS)&quot;, section on 'Management'</a>.)</p><p>Patients should be followed by serial biochemical measurements. Hepatology consultation may be warranted.</p><p>Recovery should be expected in the majority of patients after discontinuing the HDS. More advanced disease requires supportive therapy, with acute liver failure often leading to death or need for liver transplantation. In this setting, mortality can be over 80 percent. The development of jaundice (bilirubin greater than two times the upper limit of normal in the setting of an alanine aminotransferase greater than three times the upper limit of normal) following introduction of a HDS potentially portends a poor outcome and should also prompt immediate referral to a center with expertise in hepatology [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/72,73\" class=\"abstract_t\">72,73</a>]. Patients who recover from HDS induced hepatotoxicity generally have a favorable prognosis.</p><p>In the United States, the Food and Drug Administration records HDS toxicity. Cases of HDS hepatotoxicity should be reported to 1-800-332-1088 or <a href=\"http://www.fda.gov/Safety/MedWatch/HowToReport/ucm085568.htm&amp;token=SHauxSdf9qNc6lLK16E8IPbyjEFMv8mTkYk65soc8qvAwq8XhNwEtIiorCyZewFlRysrYAlkCL88XO6YcWKbKPa97iouL/Mjzu6l/ySbZiM=&amp;TOPIC_ID=3618\" target=\"_blank\" class=\"external\">http://www.fda.gov/Safety/MedWatch/HowToReport/ucm085568.htm</a>.</p><p class=\"headingAnchor\" id=\"H2358833283\"><span class=\"h1\">SPECIFIC HEPATOTOXIC HERBS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The many reports in the literature of the toxic effects of herbal remedies underscore the view that not all natural products are harmless. Hepatotoxicity may be the most frequent adverse reaction to herbal remedies [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/74,75\" class=\"abstract_t\">74,75</a>]. Some of the more frequently reported offending herbs include Chinese remedies and teas (Jin Bu Huan [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/76,77\" class=\"abstract_t\">76,77</a>], Ma-Huang [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/78-80\" class=\"abstract_t\">78-80</a>]), germander [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/56,81-86\" class=\"abstract_t\">56,81-86</a>], valerian [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/87\" class=\"abstract_t\">87</a>], mistletoe [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/88\" class=\"abstract_t\">88</a>], skullcap [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/87-89\" class=\"abstract_t\">87-89</a>], chaparral [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/90-94\" class=\"abstract_t\">90-94</a>], comfrey [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/95-99\" class=\"abstract_t\">95-99</a>], herbal teas containing toxic alkaloids [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/97,100-102\" class=\"abstract_t\">97,100-102</a>], pennyroyal oil [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/103\" class=\"abstract_t\">103</a>], and kava (<a href=\"image.htm?imageKey=GAST%2F76400\" class=\"graphic graphic_table graphicRef76400 \">table 4</a>) [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/75,104-108\" class=\"abstract_t\">75,104-108</a>]. Although liver abnormalities are frequently transient, cases of chronic liver disease and acute liver failure have been described [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/12,13,108,109\" class=\"abstract_t\">12,13,108,109</a>].</p><p>The list that follows includes some of the herbs that have been associated with hepatotoxicity. However, the list of herbal medications, dietary supplements, and medications associated with hepatic injury is long. A more complete listing can be found in the <a href=\"http://www.livertox.nih.gov/&amp;token=2zSk/UZTeO3J4oIM4h1Di9fg9utsfkFQlC3ryKItrySs0myBELRJEc3r1dIl6tjF&amp;TOPIC_ID=3618\" target=\"_blank\" class=\"external\">searchable database</a> of drugs, herbal medications, and dietary supplements developed by the National Institutes of Health [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/18\" class=\"abstract_t\">18</a>].</p><p class=\"headingAnchor\" id=\"H2569065065\"><span class=\"h2\">Pyrrolizidine alkaloids</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pyrrolizidine alkaloids (PAs) are a group of naturally occurring alkaloids based on the structure of pyrrolizidine. More than 660 PAs and PA N-oxides have been identified in over 6000 plant species throughout the world (3 to 5 percent of the world's flowering plants) (<a href=\"image.htm?imageKey=GAST%2F61224\" class=\"graphic graphic_table graphicRef61224 \">table 5</a>) [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/110,111\" class=\"abstract_t\">110,111</a>]. They are used for a variety of complaints, including arthritis, gout, and a number of infections. Over 50 percent of PAs exhibit hepatotoxicity [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/101,111\" class=\"abstract_t\">101,111</a>]. Their hepatotoxicity, which has been long recognized, is predominantly observed after exposure to the following plant families: Boraginaceae (<em>Heliotropium</em>, <em>Trichodesma</em>, <em>Symphytum </em>[Comfrey]), Compositae (<em>Senecio</em> [Bush Teas], <em>Eupatorium</em>), Crotalaria (Leguminosae), Echinacea (<em>Echinacea purpurea</em>) [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/112\" class=\"abstract_t\">112</a>], Germander (<em>Teucrium chamaedrys</em>), Greater Celandine (<em>Chelidonium majus</em>), and Scrophul-ariaceae (<em>Castilleja</em>) [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/95-97,100-102,113-115\" class=\"abstract_t\">95-97,100-102,113-115</a>]. PA poisoning is common in areas where traditional remedies are frequently used (such as Africa and India) [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/116,117\" class=\"abstract_t\">116,117</a>]. In Western countries, it is seen more sporadically. Comfrey has been removed from the market in France following numerous reports of liver damage. It remains widely available in the United States despite US Food and Drug Administration (FDA) requests to remove comfrey products from the market [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/97,118\" class=\"abstract_t\">97,118</a>].</p><p>Alkaloid toxicity usually results in moderate to severe liver damage, particularly to the hepatic central vein and sinusoidal endothelium. Hemorrhagic necrosis, hepatomegaly, ascites, and endothelial cell proliferation are also seen. This can lead to occlusion of the hepatic veins, resulting in hepatic sinusoidal obstruction syndrome (formerly veno-occlusive disease), a progressive form of portal hypertension, which often progresses to hepatic failure [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/119,120\" class=\"abstract_t\">119,120</a>]. Sinusoidal obstruction syndrome is the characteristic histologic feature of PA hepatotoxicity [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/115\" class=\"abstract_t\">115</a>]. (See <a href=\"topic.htm?path=diagnosis-of-hepatic-sinusoidal-obstruction-syndrome-veno-occlusive-disease-following-hematopoietic-cell-transplantation\" class=\"medical medical_review\">&quot;Diagnosis of hepatic sinusoidal obstruction syndrome (veno-occlusive disease) following hematopoietic cell transplantation&quot;</a>.)</p><p>The precise mechanism of hepatic injury is unknown but appears to result from accumulation of highly reactive electrophilic metabolites produced via the cytochrome P450 (CYP450) enzyme system [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/12,95,103\" class=\"abstract_t\">12,95,103</a>]. The increased concentration of P450 enzymes within the hepatic centrilobular region correlates with the changes seen histologically. The pyrrolic metabolite, dehydro riddelliine, covalently binds to cellular DNA, which have been identified in the blood [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/115\" class=\"abstract_t\">115</a>]. The damage is compounded by depletion of glutathione or induction of CYP450 3A4 [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/10,121\" class=\"abstract_t\">10,121</a>]. PAs have also been shown to induce apoptosis [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/121,122\" class=\"abstract_t\">121,122</a>].</p><p>Nonthrombotic luminal occlusion of the small centrilobular veins leads to hepatic congestion and subsequent hemorrhagic parenchymal necrosis [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/12,123\" class=\"abstract_t\">12,123</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>With acute injury, patients typically present with sudden onset abdominal pain, jaundice, conjugated hyperbilirubinemia, and elevated aminotransferases. Hepatomegaly and ascites are common.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The subacute and chronic forms are more insidious and may mimic cirrhosis and portal hypertension from other causes. However, histology shows a distinctive pattern of centrilobular injury [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/119\" class=\"abstract_t\">119</a>].</p><p/><p>Hepatotoxicity from PAs is dose and time dependent and reproducible [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/124\" class=\"abstract_t\">124</a>]. Approximately one half of patients with hepatotoxicity develop limited lesions and generally proceed to complete recovery once the offending herb has been discontinued [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/119,125\" class=\"abstract_t\">119,125</a>]. More extensive disease can lead to cirrhosis, hepatic failure, and death [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/12,14,125\" class=\"abstract_t\">12,14,125</a>]. The acute form is rapidly fatal in 20 to 40 percent of patients (with worse prognosis in adults compared with children). Approximately 15 percent with acute disease will progress to subacute or chronic injury, succumbing within several years to end stage liver disease. Of the remainder, most develop cirrhosis and portal hypertension [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/30,119,125,126\" class=\"abstract_t\">30,119,125,126</a>]. Death may occur two weeks to more than two years after poisoning, but patients may recover almost completely if the herb intake is discontinued and liver damage is not severe.</p><p class=\"headingAnchor\" id=\"H1441342082\"><span class=\"h2\">Ayurvedic herbs</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>These are herbal and dietary supplements (HDS) used most commonly on the Indian subcontinent in the practice of traditional Indian medicine (Ayurveda). Ayurveda uses many medicinal plants that contain toxic pyrrolizidine alkaloids [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/127,128\" class=\"abstract_t\">127,128</a>]. They include <em>Psoralea corylifolia</em>, <em>Centella asiatica</em>, <em>Acacia catechu</em>, <em>Eclipta alba</em>, and <em>Vetivexia</em> [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/129,130\" class=\"abstract_t\">129,130</a>]. Both acute and chronic hepatitis have been reported. Additionally, many of these products have been found to be adulterated with heavy metals, including lead, mercury, or arsenic [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/42,131\" class=\"abstract_t\">42,131</a>].</p><p class=\"headingAnchor\" id=\"H3263091012\"><span class=\"h2\">Germander</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The blossoms of germander (<em>Teucrium chamaedrys</em>) have been used for thousands of years for a variety of symptoms [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/132\" class=\"abstract_t\">132</a>]. It is used in tea form or alcohol-based extracts. The herb is said to have choleretic properties, although this has never been scientifically proven. It is also used for dyspepsia, hypertension, diabetes, gout, and obesity [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/110\" class=\"abstract_t\">110</a>]. Liver injury can present as acute hepatitis, chronic hepatitis, or acute liver failure [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/56,81,82,132,133\" class=\"abstract_t\">56,81,82,132,133</a>]. The herb has been removed from the market in France because of its hepatotoxicity [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/84,85\" class=\"abstract_t\">84,85</a>]. The majority of cases of hepatotoxicity have occurred at the manufacturers' recommended doses (600 to 1600 <span class=\"nowrap\">mg/day)</span>. Clinical symptoms generally occur after approximately two to three months of ingestion and include a nonspecific hepatitis, which generally runs a benign course [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/12\" class=\"abstract_t\">12</a>]. Typical features include anorexia, nausea, abdominal pain, and jaundice associated with a marked elevation in serum aminotransferases. Complete recovery is usually seen within two to six months following discontinuation of the herb. Fatal cases have been described, as have more insidious presentations with progression to cirrhosis [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/10,12,56,83\" class=\"abstract_t\">10,12,56,83</a>]. Cirrhosis generally develops in patients who have ingested the offending herb for longer periods of time or in larger quantities.</p><p>Germander contains toxic alkaloids, the furanic neoclerodane diterpenes (NCDs), which are oxidized by the cytochrome P450 3A4 enzyme system into hepatotoxic reactive metabolites [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/81,134\" class=\"abstract_t\">81,134</a>]. The toxic metabolites accumulate and covalently bind to cellular proteins, which in association with the depletion of the free-radical scavenger glutathione, leads to acute centrilobular hepatocyte necrosis in vivo. In vitro studies have revealed progressive apoptosis and cytoskeletal disorganization [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/13,134\" class=\"abstract_t\">13,134</a>].</p><p>Poley (<em>Teucrium polium</em>) is in the same genus as germander and is used for diabetes (in Israel), gastric complaints (in North Africa), fever (in Italy), and as a poultice (in Spain). It has also been linked to hepatotoxicity and acute liver failure [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/86,135,136\" class=\"abstract_t\">86,135,136</a>]. <em>Teucrium capitatum</em> and <em>T. viscidum</em> have also been reported to cause hepatotoxicity [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/137,138\" class=\"abstract_t\">137,138</a>].</p><p class=\"headingAnchor\" id=\"H1139068093\"><span class=\"h2\">Greater celandine</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Greater Celandine (<em>Chelidonium majus</em>) is a member of the poppy family that grows mainly in Europe and Asia but has been introduced into North America. It is considered a &quot;cleansing&quot; herb and is said to stimulate pancreatic enzymes and bile. In fact, it has been shown to increase biliary flow in experimental models [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/139\" class=\"abstract_t\">139</a>]. Therefore, it is often used for hepatobiliary (jaundice, hepatitis, and gallbladder) and digestive tract (dyspepsia, gastroenteritis, irritable bowel syndrome, constipation, anorexia, stomach cancer, intestinal polyps) complaints [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/140\" class=\"abstract_t\">140</a>]. The plant contains over 20 alkaloids [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/140\" class=\"abstract_t\">140</a>]. When used orally, it has been implicated numerous cases of liver injury [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/114,140-147\" class=\"abstract_t\">114,140-147</a>]. Jaundice is generally the predominant symptom, but anorexia, nausea, vomiting, abdominal pain and itching have been reported. Liver enzyme elevations range from 100 to over 4,000 <span class=\"nowrap\">units/L,</span> and injury is hepatocellular and idiosyncratic in the majority of cases [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/147\" class=\"abstract_t\">147</a>]. However, cholestatic hepatitis has also been reported [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/114,141\" class=\"abstract_t\">114,141</a>]. The mechanism of hepatotoxicity is unclear. Liver injury appears to show a female predominance [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/147,148\" class=\"abstract_t\">147,148</a>]. Histologic examination of the involved liver has suggested metabolic hepatotoxicity [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/114,141,147\" class=\"abstract_t\">114,141,147</a>]. There have been no reports of fatalities and discontinuing generally leads to resolution of liver injury over two to six months. Greater celandine has been banned from use in many European countries.</p><p class=\"headingAnchor\" id=\"H792097579\"><span class=\"h2\">Chaparral</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Chaparral (<em>Larrea tridentata</em>) is indigenous to the southwestern United States and is derived from the leaves of the creosote bush (greasewood). It is said to have antiamebic, antibacterial, antifungal, and antiviral properties. It is used for diarrhea, cramps, chest pain, upper respiratory tract infections, rheumatism, cutaneous venereal lesions, chronic skin disorders, weight loss, and as a &quot;liver tonic&quot; [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/125\" class=\"abstract_t\">125</a>]. It has been popular among patients with HIV infection [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/149\" class=\"abstract_t\">149</a>]. It is available in the form of tea, capsules, tablets, and salves [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/90\" class=\"abstract_t\">90</a>]. Scientific evidence regarding Chaparral&rsquo;s effectiveness is lacking.</p><p>Patients with chaparral-induced hepatotoxicity typically present with acute hepatitis [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/90\" class=\"abstract_t\">90</a>]. Marked elevation in the serum aminotransferase and bilirubin values may be seen. Alkaline phosphatase may be mildly elevated. Acute hepatocellular injury of varying degrees of severity has been reported, including mild cholestatic hepatitis, severe collapse of parenchymal architecture, hepatic fibrosis, and massive liver failure requiring transplantation [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/90-94,150\" class=\"abstract_t\">90-94,150</a>]. The onset of disease occurs 3 to 52 weeks after the ingestion and resolves in 1 to 17 weeks in most cases [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/90\" class=\"abstract_t\">90</a>]. Progression to cirrhosis or acute liver failure requiring liver transplantation has been reported [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/90\" class=\"abstract_t\">90</a>].</p><p>Chaparral's presumed therapeutic mechanism of action is secondary to the powerful antioxidant nordihydroguaiaretic acid (NDGA), which inhibits induction of ornithine decarboxylase, and inhibits the cyclooxygenase (P-450 mono-oxygenase), and lipoxygenase pathways [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/91\" class=\"abstract_t\">91</a>]. Protein synthesis appears to be inhibited and the Golgi complexes are irreversibly damaged [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/151\" class=\"abstract_t\">151</a>]. </p><p class=\"headingAnchor\" id=\"H1716929119\"><span class=\"h2\">Atractylis gummifera and callilepis laureola</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Atractylis gummifera grows in the Mediterranean and is used as an antipyretic, emetic, abortifacient, and diuretic, and hepatotoxicity continues to be reported [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/12,152,153\" class=\"abstract_t\">12,152,153</a>]. Toxicity is secondary to two diterpenoid glucosides: atractyloside and carboxyatractyloside [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/154\" class=\"abstract_t\">154</a>]. These toxins inhibit mitochondrial oxidative phosphorylation by interacting with a mitochondrial adenine nucleotide translocator, inducing oxidative stress [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/154,155\" class=\"abstract_t\">154,155</a>]. The onset of toxicity is rapid, occurring within hours after ingestion. It often leads to acute liver and kidney failure and subsequent death.</p><p>Callilepis laureola (Impila) is native to South Africa [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/156,157\" class=\"abstract_t\">156,157</a>]. Like <em>A. gummifera</em>, it contains atractyloside. It has a similar rapid onset of action and mortality rates are over 90 percent by five days after ingestion.</p><p class=\"headingAnchor\" id=\"H2510559153\"><span class=\"h2\">Pennyroyal</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pennyroyal (<em>Mentha pulegium</em>) is a highly toxic agent that can cause both hepatic and neurologic injury. It is frequently used to flavor herbal remedies and teas (particularly mint teas) and is often used for digestive disorders, liver disorders, amenorrhea, gout, colds, increased micturition, and for skin diseases. It also continues to be used as an abortifacient. Acute toxicity leads to gastrointestinal distress and central nervous system (CNS) effects within one to two hours of ingestion (up to 10 mL of the oil), and fatal ingestions can occur with ingestion of &gt;15 mL of the oil [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/158\" class=\"abstract_t\">158</a>].</p><p>The P450-induced oxidative metabolites (menthofuran) of the active compound pulegone are associated with severe hepatic toxicity from centrilobular degeneration and massive necrosis [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/125\" class=\"abstract_t\">125</a>]. These metabolites bind to cellular proteins and deplete hepatic glutathione [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/103,159,160\" class=\"abstract_t\">103,159,160</a>]. The use of N-acetylcysteine may help minimize hepatic injury [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/158\" class=\"abstract_t\">158</a>].</p><p class=\"headingAnchor\" id=\"H4009848262\"><span class=\"h2\">Mistletoe</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mistletoe (<em>Viscum album</em>) is purported to be effective in treating asthma, epilepsy, arteriosclerosis, cardiac arrhythmia, cramps, blood loss, nervous conditions, high blood pressure, joint pain, dizziness, infertility, and is used as an aphrodisiac [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/88\" class=\"abstract_t\">88</a>]. There have been case reports of hepatitis [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/88\" class=\"abstract_t\">88</a>]. Lectins in the product induce apoptosis and can also stimulate the immune system [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/26\" class=\"abstract_t\">26</a>]. However, controversy remains as to whether mistletoe actually causes disease. In reported cases, the ingested capsules were also laced with Skullcap (<em>Scutellaria galericulata</em>). Skullcap and Valerian (<em>Valeriana officinalis</em>) have been implicated in liver injury, although there are no experimental data supporting their toxicity [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/12,14,87\" class=\"abstract_t\">12,14,87</a>].</p><p class=\"headingAnchor\" id=\"H30074381\"><span class=\"h2\">Kava kava</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Kava kava (<em>Piper methysticum</em>) is used as a dietary supplement and has been used in the South Pacific for centuries for complaints of anxiety, sleeplessness, and menopausal symptoms. Numerous reports of severe hepatotoxicity and liver failure have been described in Europe and the United States [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/75,104-108,161-163\" class=\"abstract_t\">75,104-108,161-163</a>]. Hepatotoxicity has been reported within a few weeks to up to two years (average 4.5 months) following ingestion [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/161\" class=\"abstract_t\">161</a>].</p><p>Clinically, reports of toxicity range from transient elevation in aminotransferases to acute liver failure and death [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/75\" class=\"abstract_t\">75</a>]. Liver injury has been characterized histologically with hepatic necrosis, cholestatic hepatitis, and lobular hepatitis. The mechanism of hepatotoxicity is unclear, but multiple hepatotoxic components have been identified, including pipermethystine and flavokavain B [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/164,165\" class=\"abstract_t\">164,165</a>]. The aerial portions of the plant contain the toxic alkaloid pipermethysticin and are generally not consumed [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/164,165\" class=\"abstract_t\">164,165</a>].</p><p>Based upon case reports of serious toxicity, the US Food and Drug Administration issued a consumer advisory in November 2002 regarding this toxic herbal product. Details of the advisory are available <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5147a1.htm&amp;token=mjmpv7xMHRIW2nr+3NCnsbCRzI0l2D55/Qbax/5ovYdGo+61O6wu/JwRF6vwJMqOuX38zRF8zJ4gp9DSexuurQ==&amp;TOPIC_ID=3618\" target=\"_blank\" class=\"external\">online</a>. The product has been banned from many European markets. The link of toxicity to Kava kava remains debated [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/164\" class=\"abstract_t\">164</a>]. Some propose that the aqueous preparation is safe [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/166\" class=\"abstract_t\">166</a>], while others have shown that even this preparation leads to hepatotoxicity [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/167\" class=\"abstract_t\">167</a>].</p><p class=\"headingAnchor\" id=\"H2923594748\"><span class=\"h2\">Green tea extracts</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Extracts of Chinese green tea (<em>Camellia sinensis L.</em>) are commonly used and have been associated with hepatocellular injury [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/168-170\" class=\"abstract_t\">168-170</a>]. In general, drinking green tea in moderation appears to be safe and may have beneficial effects. However, numerous supplement extracts are available and have been reported to cause liver injury. These extracts have been used in multiple weight-loss products, many of which have been removed from the market due to toxicity. The mechanism of hepatotoxicity remains unclear. Catechins such as epigallocatechin-3-gallate (EGCG) are likely to be involved. EGCG induces reactive oxygen species similar to other herbal products [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/171\" class=\"abstract_t\">171</a>]. A genetic predisposition may also predispose to injury, and women are more susceptible than men [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/168,172\" class=\"abstract_t\">168,172</a>]. Hepatotoxicity is increased in those who are fasting [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/112\" class=\"abstract_t\">112</a>]. The pattern of injury is predominantly hepatocellular, but mixed and cholestatic presentations have been reported [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/171,173\" class=\"abstract_t\">171,173</a>]. Liver injury generally develops within three months of use and usually resolves with discontinuation of the product.</p><p class=\"headingAnchor\" id=\"H668755844\"><span class=\"h2\">Androgenic anabolic steroids</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Anabolic steroid use has long been associated with many types of liver injury, including hepatitis, intrahepatic cholestasis, peliosis hepatis, hepatic adenoma, and hepatocellular carcinoma [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/174,175\" class=\"abstract_t\">174,175</a>]. They were first identified and synthesized in the 1930s, classified as a class III controlled substance in 1991, and further regulated in 2004 [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/20\" class=\"abstract_t\">20</a>]. Despite their regulation and well-known hepatic toxicity, their use remains widespread, and patients continue to present with hepatotoxicity [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/176,177\" class=\"abstract_t\">176,177</a>]. The classic presentation is one of hepatocellular injury with severe jaundice a median of approximately 70 days following use [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/178\" class=\"abstract_t\">178</a>]. Patients who present with markedly elevated bilirubin levels are also prone to acute renal injury [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/26\" class=\"abstract_t\">26</a>]. The FDA has issued a public health advisory warning consumers to stop using any body building products that are represented to contain anabolic steroids or steroid-like substances [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/179\" class=\"abstract_t\">179</a>].</p><p class=\"headingAnchor\" id=\"H1353834277\"><span class=\"h2\">Black cohosh</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Black cohosh (<em>Actaea racemosa</em>) is indigenous to eastern North America. It is widely available and the rhizomes and roots are commonly used for the treatment of peri- and postmenopausal symptoms. The product contains many compounds, including phenolic acids, flavonoids, volatile oils, triterpene glycosides, and tannins [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/112\" class=\"abstract_t\">112</a>]. There have been multiple reports of hepatotoxicity and adulteration [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/180,181\" class=\"abstract_t\">180,181</a>]. Generally, this HDS results in an autoimmune-type of liver injury, and liver failure necessitating transplantation has been reported [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/112,180,182-185\" class=\"abstract_t\">112,180,182-185</a>]. However, the causality between black cohosh and hepatotoxicity remains uncertain.</p><p class=\"headingAnchor\" id=\"H1537314118\"><span class=\"h2\">Flavocoxid</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=flavocoxid-united-states-note-fda-has-issued-a-warning-against-use-of-this-product-drug-information\" class=\"drug drug_general\">Flavocoxid</a> is a prescription medical food that is a blend of two flavonoids, baicalin and catechins (derived from the plants <em>Scutellaria baicalensis</em> and <em>Acacia catechu</em>, respectively). It is used to treat osteoarthritis. In November 2017, the United States Food and Drug Administration recommended immediate discontinuation of flavocoxid because of reports of serious adverse events, including drug-induced liver injury [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/186\" class=\"abstract_t\">186</a>]. In a prospective study of 877 patients, four patients (0.4 percent) developed liver injury [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/187\" class=\"abstract_t\">187</a>]. The association between flavocoxid use and liver injury was deemed highly likely in three cases and possible in one. In all four cases, liver tests returned to normal within 3 to 12 weeks of discontinuing the flavocoxid.</p><p class=\"headingAnchor\" id=\"H2414263929\"><span class=\"h1\">CHINESE HERBAL REMEDIES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Over 11,000 species of medicinal plants are used in China with a projected $400 billion market by 2010 [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/112,188\" class=\"abstract_t\">112,188</a>]. Many have beneficial effects [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/32\" class=\"abstract_t\">32</a>]. However, hepatotoxicity has been reported with at least 10 species [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/32,75,76,80,189-191\" class=\"abstract_t\">32,75,76,80,189-191</a>] and ranges from mild toxic hepatitis [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/189,190\" class=\"abstract_t\">189,190</a>] to acute liver failure and death or liver transplantation [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/109\" class=\"abstract_t\">109</a>]. It is often difficult to identify the agent responsible for the hepatotoxicity since most Chinese preparations are either concoctions of multiple herbal preparations (typically four to six different herbs) or have been adulterated with substituted herbs, heavy metals, or pharmaceutical medicines [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/12-14,29,31,33-36,46,47,129\" class=\"abstract_t\">12-14,29,31,33-36,46,47,129</a>]. Generally, a single herb is considered primary (the &quot;king&quot; or &quot;sovereign&quot;), while the additional herbs are thought to act synergistically with the main product or to modify its toxicity [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/17\" class=\"abstract_t\">17</a>]. Toxicity is generally observed with preparations that contain aconitine, podophyllin, or anticholinergics [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/190\" class=\"abstract_t\">190</a>].</p><p class=\"headingAnchor\" id=\"H2587798319\"><span class=\"h2\">Jin Bu Huan</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Jin Bu Huan (<em>Lycopodium serratum</em>) has been used for over 1000 years as a sedative and analgesic [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/76,132,133\" class=\"abstract_t\">76,132,133</a>]. It has morphine-like properties due to the alkaloid levo-tetrahydropalmatine. It was banned for use in the United States in the 1990s following multiple reports of toxicity [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/76,77,192\" class=\"abstract_t\">76,77,192</a>]. </p><p>Both acute and chronic hepatotoxicity have been reported [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/76,77,192\" class=\"abstract_t\">76,77,192</a>]. Patients with hepatotoxicity present at a mean of 20 weeks (7 to 52 weeks) after ingestion with acute hepatitis associated with fever, nausea, vomiting, fatigue, pruritus, abdominal pain, hepatomegaly, and jaundice. Plasma aminotransferase levels are significantly elevated. The liver biopsies that have been performed appear consistent with a drug-induced liver injury, demonstrating eosinophils and focal hepatocellular necrosis [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/76,77\" class=\"abstract_t\">76,77</a>]. Fibrosis and microvesicular steatosis have also been reported [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/76\" class=\"abstract_t\">76</a>].</p><p>Symptoms resolve over a mean of eight weeks (2 to 30 weeks) with discontinuation of the herb and have promptly recurred when patients were rechallenged [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/76,77\" class=\"abstract_t\">76,77</a>]. The hepatotoxic mechanism is not known but may be immunologic given the histologic presentation [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/132\" class=\"abstract_t\">132</a>].</p><p class=\"headingAnchor\" id=\"H2774112036\"><span class=\"h2\">Ma-Huang (ephedra)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ma-Huang (<em>Ephedra sinica</em>), an ephedra alkaloid, has been used for centuries for cough, bronchitis, fever, joint symptoms, edema, bone pain, to induce weight loss, and as a central nervous system (CNS) stimulant [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/78,80\" class=\"abstract_t\">78,80</a>]. The active ingredient is <a href=\"topic.htm?path=ephedrine-systemic-drug-information\" class=\"drug drug_general\">ephedrine</a>, and has been associated with psychiatric and autonomic system adverse events. Reports of hepatotoxicity have also been associated with use of the drug, including hepatitis, acute liver failure, and exacerbation of autoimmune hepatitis [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/78-80,193,194\" class=\"abstract_t\">78-80,193,194</a>]. The mechanism of toxicity is not known.</p><p>Affected patients present in similar fashion to those taking Jin Bu Huan [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/78,80\" class=\"abstract_t\">78,80</a>]. Biopsies revealed diffuse severe hepatocellular necrosis and polymorphonuclear cell infiltrates with occasional eosinophils. Abnormal liver tests usually normalize within four months of discontinuation of drug [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/194\" class=\"abstract_t\">194</a>]. Ephedra has been withdrawn from the United States market.</p><p class=\"headingAnchor\" id=\"H273521750\"><span class=\"h2\">Syo-saiko-to</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Syo-saiko-to (Dai-saiko-to, xiao-chai-hu-tang, da-chai-hu-tang, TJ-19) is a Chinese herbal product used in Japan that contains numerous herbs (Bupleuri root, Pinelliae tuber, Scutellaria root, ginseng root, ginger rhizome, glycyrrhiza root, and jujube fruit). The products differ in their proportion of herbal products. It is being used increasingly in the treatment of hepatitis C virus infection. There is some evidence that these products may have anti-inflammatory, antifibrotic, and antitumorigenic activity [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/195\" class=\"abstract_t\">195</a>]. There have been multiple reports of hepatotoxicity associated with this product; however, some occurring up to three months after ingestion and recurring with rechallenge [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/196-198\" class=\"abstract_t\">196-198</a>]. The histologic picture is one of centrilobular confluent or spotty necrosis, microvesicular steatosis, acidophil bodies, and possibly granulomas [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/196\" class=\"abstract_t\">196</a>]. Patients should be cautioned against using this herbal remedy.</p><p class=\"headingAnchor\" id=\"H3408867466\"><span class=\"h2\">Chaso or Onshido</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Chaso and Onishido are used for weight loss. The toxic ingredient in these formulations is thought to be N-nitroso-fenfluramine, which depletes adenosine triphosphate (ATP) and impairs mitochondrial oxidative phosphorylation [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/26\" class=\"abstract_t\">26</a>]. This results in diffuse hepatic necrosis and nonspecific inflammation. Cases of acute liver failure, death, and liver transplantation have been reported [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/199\" class=\"abstract_t\">199</a>].</p><p class=\"headingAnchor\" id=\"H3842336760\"><span class=\"h1\">WEIGHT LOSS PRODUCTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Numerous proprietary preparations have been associated with hepatotoxicity, including Hydroxycut [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/200-206\" class=\"abstract_t\">200-206</a>], Herbalife [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/40,207-212\" class=\"abstract_t\">40,207-212</a>], Enzyte [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/213\" class=\"abstract_t\">213</a>], N.O.-XPLODE [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/178\" class=\"abstract_t\">178</a>], OxyELITE [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/214\" class=\"abstract_t\">214</a>], SlimQuick [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/172\" class=\"abstract_t\">172</a>], Exolise [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/172,173\" class=\"abstract_t\">172,173</a>].</p><p class=\"headingAnchor\" id=\"H1293012867\"><span class=\"h2\">Herbalife products</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>These products are sold worldwide in the form of drinks, tablets, capsules, and energy bars. Sales in the United States are over three billion dollars [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/215\" class=\"abstract_t\">215</a>]. There are multiple reports of hepatotoxicity with these products, ranging from mild to severe enough to require liver transplantation [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/40,207,209-211,215,216\" class=\"abstract_t\">40,207,209-211,215,216</a>]. The pattern of liver injury is hepatocellular in the majority of cases; however, there are also reports of both mixed and cholestatic injury. The mechanism of toxicity remains unknown.</p><p class=\"headingAnchor\" id=\"H3552017098\"><span class=\"h2\">Hydroxycut</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hydroxycut is another popular weight loss product that contains multiple herbal products. Again, most had hepatocellular injury, but other patterns were reported as well. The original formulation included <em>Camellia sinensis</em> (117 mg EGCG). In 2009, the FDA issued a warning regarding the product&rsquo;s potential hepatotoxicity and recommended that consumers discontinue use of the products carrying the brand name Hydroxycut [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/188,204,215,217,218\" class=\"abstract_t\">188,204,215,217,218</a>]. The manufacturer voluntarily recalled all of its products, reformulated the herbal mix, and this new formulation is now being sold [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/215\" class=\"abstract_t\">215</a>].</p><p class=\"headingAnchor\" id=\"H530693390\"><span class=\"h2\">OxyELITE Pro</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Seven Hawaiian patients presented in 2013 with severe hepatitis or acute liver failure. All were taking the product OxyELITE Pro [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/219\" class=\"abstract_t\">219</a>]. Further investigation identified an additional 52 cases of acute hepatitis, the majority of which had taken this product. The FDA then initiated an investigation into the manufacture and distribution of OxyELITE Pro [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/214\" class=\"abstract_t\">214</a>]. They identified multiple reports of toxicity in the continental United States, the majority of whom were young (mean age 33.9 years) and male (60 percent). Sixty-nine patients had consumed OxyELITE Pro, and 32 required hospitalization, three required liver transplantation, and one died [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/214\" class=\"abstract_t\">214</a>]. The original product contained 1,2-dimethylamylamine (DMAA), which had been noted to have caused acute liver injury [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/220\" class=\"abstract_t\">220</a>]. The formulation was changed in 2013 by the manufacturer to remove DMAA, and add aegeline [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/221\" class=\"abstract_t\">221</a>]. Aegeline is extracted from <em>Aegle marmelos (bael)</em>, and has been used in Ayurvedic medicine. Its main alkaloid is N-[2-hydroxy-2(4-methoxyphenyl) ethyl]-3-phenyl-2-propenamide The FDA had not been informed of this change and the manufacturer issued a recall in November 2013.</p><p class=\"headingAnchor\" id=\"H1150564995\"><span class=\"h1\">OTHER HEPATOTOXIC HERBS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are many case reports of hepatotoxicity with other herbal preparations. These include Aloe (<em>A. vera; A. barbadensis, A. arborescens</em>), Bajiaolian, Borage (<em>Borago officinalis</em>), Broom Corn (<em>Sorghum vulgare</em>), <a href=\"topic.htm?path=camphor-drug-information\" class=\"drug drug_general\">Camphor</a> oil, <em>Centella asiatica </em>(gotu kola), Margosa oil (<em>Azadirachza indica</em>), Cocaine, Coltsfoot, Copaltra (<em>Coutarea latiflora</em> and <em>Centaurium erythraea</em>), Kombucha tea, LipoKinetix (a capsule used for weight loss that contains multiple ingredients including usnic acid from the lichen <em>Usnea barbata</em>), Noni juice (<em>Morinda citrifolia</em>), <em>Cascara sagrada</em>, Sassafras (<em>Sassafras albidum</em>), and <a href=\"topic.htm?path=senna-drug-information\" class=\"drug drug_general\">Senna</a> (<em>Cassia angustifolia</em>) [<a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/12,14,30,75,125,132,133,141,173,199,208,222-233\" class=\"abstract_t\">12,14,30,75,125,132,133,141,173,199,208,222-233</a>].</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=toxic-hepatitis-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Toxic hepatitis (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H24\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Herbal remedies may be associated with hepatotoxicity, making it important to discuss the use of herbal and dietary supplements (HDS) and complementary and alternative medical (CAM) therapies in an attempt to prevent potential complications, such as herb-drug interactions. (See <a href=\"topic.htm?path=overview-of-herbal-medicine-and-dietary-supplements\" class=\"medical medical_review\">&quot;Overview of herbal medicine and dietary supplements&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The use of herbal remedies should be considered as a possible etiology in any setting of clinical manifestations of liver injury.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Proving that an herbal or dietary supplement causes liver injury relies on both chronological and clinical criteria. Features suggesting drug toxicity include lack of illness prior to ingesting the drug, clinical illness or biochemical abnormalities developing after beginning the drug, and improvement after the product is withdrawn. (See <a href=\"#H3762083709\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Obtaining a sample of the implicated HDS or CAM therapies for testing is possible, but expertise is not widely available. Costs are generally prohibitive, and most research laboratories are capable of testing only for certain compounds.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The mainstay of therapy for herbal hepatotoxicity is withdrawal of the offending toxin and supportive care. (See <a href=\"#H734050788\" class=\"local\">'Treatment'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A <a href=\"http://www.livertox.nih.gov/&amp;token=2zSk/UZTeO3J4oIM4h1Di9fg9utsfkFQlC3ryKItrySs0myBELRJEc3r1dIl6tjF&amp;TOPIC_ID=3618\" target=\"_blank\" class=\"external\">searchable database</a> of drugs, herbal medications, and dietary supplements has been developed by the National Institutes of Health.</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/1\" class=\"nounderline abstract_t\">Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med 2005; 11:42.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/2\" class=\"nounderline abstract_t\">A Lindstrom, C Ooyen, ME Lynch, et al. Sales of herbal dietary supplements increase by 7.9% in 2013, makring a decade of rising sales. HerbalGram 2014; 103:52.</a></li><li class=\"breakAll\">Complementary and Alternative Medicine in the United States. Institute of Medicine Committee on the Use of Complementary and Alternative Medicine by the American Public; National Academies Press (US), Washington (DC), 2005.</li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/4\" class=\"nounderline abstract_t\">Bailey RL, Gahche JJ, Lentino CV, et al. Dietary supplement use in the United States, 2003-2006. J Nutr 2011; 141:261.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/5\" class=\"nounderline abstract_t\">Nahin RL, Barnes PM, Stussman BJ. Expenditures on Complementary Health Approaches: United States, 2012. Natl Health Stat Report 2016; :1.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/6\" class=\"nounderline abstract_t\">A Lindstrom, C Ooyen, ME Lynch, et al. Sales of herbal dietary supplements increase by 7.9% in 2013, marking a decade of rising sales. HerbalGram 2014; 103:52.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/7\" class=\"nounderline abstract_t\">Bailey RL, Gahche JJ, Miller PE, et al. Why US adults use dietary supplements. JAMA Intern Med 2013; 173:355.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/8\" class=\"nounderline abstract_t\">Ni H, Simile C, Hardy AM. Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey. Med Care 2002; 40:353.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/9\" class=\"nounderline abstract_t\">Graham RE, Ahn AC, Davis RB, et al. Use of complementary and alternative medical therapies among racial and ethnic minority adults: results from the 2002 National Health Interview Survey. J Natl Med Assoc 2005; 97:535.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/10\" class=\"nounderline abstract_t\">Schuppan D, Jia JD, Brinkhaus B, Hahn EG. Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology 1999; 30:1099.</a></li><li class=\"breakAll\">Swerdlow JL.. Nature's Medicine: Plants That Heal., National Geographic, Washington, DC 2000.</li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/12\" class=\"nounderline abstract_t\">Larrey D, Pageaux GP. Hepatotoxicity of herbal remedies and mushrooms. Semin Liver Dis 1995; 15:183.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/13\" class=\"nounderline abstract_t\">Kaplowitz N. Hepatotoxicity of herbal remedies: insights into the intricacies of plant-animal warfare and cell death. Gastroenterology 1997; 113:1408.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/14\" class=\"nounderline abstract_t\">Larrey D. Hepatotoxicity of herbal remedies. J Hepatol 1997; 26 Suppl 1:47.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/15\" class=\"nounderline abstract_t\">Eisenberg DM, Kessler RC, Van Rompay MI, et al. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med 2001; 135:344.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/16\" class=\"nounderline abstract_t\">Stirnimann G, Kessebohm K, Lauterburg B. Liver injury caused by drugs: an update. Swiss Med Wkly 2010; 140:w13080.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/17\" class=\"nounderline abstract_t\">Bunchorntavakul C, Reddy KR. Review article: herbal and dietary supplement hepatotoxicity. Aliment Pharmacol Ther 2013; 37:3.</a></li><li class=\"breakAll\">http://www.livertox.nih.gov/ (Accessed on August 03, 2016).</li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/19\" class=\"nounderline abstract_t\">Goldman P. Herbal medicines today and the roots of modern pharmacology. Ann Intern Med 2001; 135:594.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/20\" class=\"nounderline abstract_t\">Navarro VJ. Herbal and dietary supplement hepatotoxicity. Semin Liver Dis 2009; 29:373.</a></li><li class=\"breakAll\">US Food and Drug Administration. Information for consumers: Dietary supplements. US Food and Drug Administration. http://www.fda.gov/Food/DietarySupplements/ConsumerInformation/default.htm (Accessed on August 03, 2016).</li><li class=\"breakAll\">Federal Food, Drug, and Cosmetic Act (FD&amp;C) Act http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/default.htm (Accessed on August 02, 2016).</li><li class=\"breakAll\">United States Pharmacopeia (USP). About USP - an overview http://www.usp.org/aboutUSP (Accessed on August 03, 2016).</li><li class=\"breakAll\">US Food and Drug Administration. Center for Food Safety and Applied Nutrition. Dietary Supplements http://www.fda.gov/Food/DietarySupplements/default.htm (Accessed on July 10, 2012).</li><li class=\"breakAll\">http://www.fda.gov/regulatoryinformation/legislation/significantamendmentstothefdcact/ucm148003.htm. (Accessed on August 03, 2016).</li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/26\" class=\"nounderline abstract_t\">Navarro VJ, Lucena MI. Hepatotoxicity induced by herbal and dietary supplements. Semin Liver Dis 2014; 34:172.</a></li><li class=\"breakAll\">US Food and Drug Administration. Claims that can be made for conventional foods and dietary supplements http://www.fda.gov/Food/LabelingNutrition/LabelClaims/ucm111447.htm (Accessed on August 03, 2016).</li><li class=\"breakAll\">US Food and Drug Administration. Guidance, Compliance &amp; Regulatory Information http://www.fda.gov/food/DietarySupplements/GuidanceComplianceRegulatoryInformation (Accessed on August 03, 2016).</li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/29\" class=\"nounderline abstract_t\">Tomlinson B, Chan TY, Chan JC, et al. Toxicity of complementary therapies: an eastern perspective. J Clin Pharmacol 2000; 40:451.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/30\" class=\"nounderline abstract_t\">Cole MR, Fetrow CW. Adulteration of dietary supplements. Am J Health Syst Pharm 2003; 60:1576.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/31\" class=\"nounderline abstract_t\">Ernst E. Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharmacol Sci 2002; 23:136.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/32\" class=\"nounderline abstract_t\">Chan TY, Chan JC, Tomlinson B, Critchley JA. Chinese herbal medicines revisited: a Hong Kong perspective. Lancet 1993; 342:1532.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/33\" class=\"nounderline abstract_t\">Ko RJ. Adulterants in Asian patent medicines. N Engl J Med 1998; 339:847.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/34\" class=\"nounderline abstract_t\">Chan TY, Critchley JA. Usage and adverse effects of Chinese herbal medicines. Hum Exp Toxicol 1996; 15:5.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/35\" class=\"nounderline abstract_t\">Huang WF, Wen KC, Hsiao ML. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 1997; 37:344.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/36\" class=\"nounderline abstract_t\">Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Intern Med 2002; 252:107.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/37\" class=\"nounderline abstract_t\">Espinoza EO, Mann MJ, Bleasdell B. Arsenic and mercury in traditional Chinese herbal balls. N Engl J Med 1995; 333:803.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/38\" class=\"nounderline abstract_t\">Gertner E, Marshall PS, Filandrinos D, et al. Complications resulting from the use of Chinese herbal medications containing undeclared prescription drugs. Arthritis Rheum 1995; 38:614.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/39\" class=\"nounderline abstract_t\">Kang-Yum E, Oransky SH. Chinese patent medicine as a potential source of mercury poisoning. Vet Hum Toxicol 1992; 34:235.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/40\" class=\"nounderline abstract_t\">Stickel F, Droz S, Patsenker E, et al. Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis. J Hepatol 2009; 50:111.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/41\" class=\"nounderline abstract_t\">Kennedy J. Herb and supplement use in the US adult population. Clin Ther 2005; 27:1847.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/42\" class=\"nounderline abstract_t\">Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA 2008; 300:915.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/43\" class=\"nounderline abstract_t\">Kales SN, Christophi CA, Saper RB. Hematopoietic toxicity from lead-containing Ayurvedic medications. Med Sci Monit 2007; 13:CR295.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/44\" class=\"nounderline abstract_t\">Nissan R, Poperno A, Stein GY, et al. A Case of Hepatotoxicity Induced by Adulterated &quot;Tiger King&quot;, a Chinese Herbal Medicine Containing Sildenafil. Curr Drug Saf 2016; 11:184.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/45\" class=\"nounderline abstract_t\">Medina-Caliz I, Gonzalez-Jimenez A, Bessone F, et al. Variations in drug-induced liver injury (DILI) between different prospective DILI registries. Clin Ther 2013; 35:S24.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/46\" class=\"nounderline abstract_t\">Miller GM, Stripp R. A study of western pharmaceuticals contained within samples of Chinese herbal/patent medicines collected from New York City's Chinatown. Leg Med (Tokyo) 2007; 9:258.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/47\" class=\"nounderline abstract_t\">Fleshner N, Harvey M, Adomat H, et al. Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors. J Urol 2005; 174:636.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/48\" class=\"nounderline abstract_t\">Seeff LB, Lindsay KL, Bacon BR, et al. Complementary and alternative medicine in chronic liver disease. Hepatology 2001; 34:595.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/49\" class=\"nounderline abstract_t\">Harkey MR, Henderson GL, Gershwin ME, et al. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr 2001; 73:1101.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/50\" class=\"nounderline abstract_t\">Ye F, Wang H, Jiang S, et al. Quality evaluation of commercial extracts of Scutellaria baicalensis. Nutr Cancer 2004; 49:217.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/51\" class=\"nounderline abstract_t\">Koff RS. Herbal hepatotoxicity. Revisiting a dangerous alternative. JAMA 1995; 273:502.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/52\" class=\"nounderline abstract_t\">Navarro VJ, Barnhart H, Bonkovsky HL, et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology 2014; 60:1399.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/53\" class=\"nounderline abstract_t\">Bessone F, Hernandez N, Sanchez A, et al. The Spanish-Latin American DILI Network: Preliminary results from a collaborative strategic initiative. J Hepatol 2013; 58:S212.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/54\" class=\"nounderline abstract_t\">Suk KT, Kim DJ, Kim CH, et al. A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol 2012; 107:1380.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/55\" class=\"nounderline abstract_t\">Zimmerman HJ, Ishak KG. General aspects of drug-induced liver disease. Gastroenterol Clin North Am 1995; 24:739.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/56\" class=\"nounderline abstract_t\">Larrey D, Vial T, Pauwels A, et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992; 117:129.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/57\" class=\"nounderline abstract_t\">Reuben A, Koch DG, Lee WM, Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010; 52:2065.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/58\" class=\"nounderline abstract_t\">Andrade RJ, Lucena MI, Fern&aacute;ndez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005; 129:512.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/59\" class=\"nounderline abstract_t\">Bj&ouml;rnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005; 42:481.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/60\" class=\"nounderline abstract_t\">Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis 2002; 22:145.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/61\" class=\"nounderline abstract_t\">Hayashi PH. Causality assessment in drug-induced liver injury. Semin Liver Dis 2009; 29:348.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/62\" class=\"nounderline abstract_t\">B&eacute;nichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990; 11:272.</a></li><li class=\"breakAll\">USFDA Guidance for Industry. Drug-Induced Liver Injury: Premarketing Clinical Evaluation www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM174090.pdf (Accessed on August 03, 2016).</li><li class=\"breakAll\">Navaro V. Hepatic adverse event nomenclature document http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/ucm080336.htm (Accessed on December 14, 2011).</li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/65\" class=\"nounderline abstract_t\">Lucena MI, Camargo R, Andrade RJ, et al. Comparison of two clinical scales for causality assessment in hepatotoxicity. Hepatology 2001; 33:123.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/66\" class=\"nounderline abstract_t\">Kaplowitz N. Causality assessment versus guilt-by-association in drug hepatotoxicity. Hepatology 2001; 33:308.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/67\" class=\"nounderline abstract_t\">Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993; 46:1331.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/68\" class=\"nounderline abstract_t\">Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997; 26:664.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/69\" class=\"nounderline abstract_t\">Rockey DC, Seeff LB, Rochon J, et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology 2010; 51:2117.</a></li><li class=\"breakAll\">Navaro V. Hepatic adverse event nomenclature document http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/ucm080336.htm (Accessed on August 03, 2016).</li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/71\" class=\"nounderline abstract_t\">O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/72\" class=\"nounderline abstract_t\">Bj&ouml;rnsson E. Drug-induced liver injury: Hy's rule revisited. Clin Pharmacol Ther 2006; 79:521.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/73\" class=\"nounderline abstract_t\">Reuben A. Hy's law. Hepatology 2004; 39:574.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/74\" class=\"nounderline abstract_t\">Shaw D, Leon C, Kolev S, Murray V. Traditional remedies and food supplements. A 5-year toxicological study (1991-1995). Drug Saf 1997; 17:342.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/75\" class=\"nounderline abstract_t\">Pittler MH, Ernst E. Systematic review: hepatotoxic events associated with herbal medicinal products. Aliment Pharmacol Ther 2003; 18:451.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/76\" class=\"nounderline abstract_t\">Woolf GM, Petrovic LM, Rojter SE, et al. Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann Intern Med 1994; 121:729.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/77\" class=\"nounderline abstract_t\">Picciotto A, Campo N, Brizzolara R, et al. Chronic hepatitis induced by Jin Bu Huan. J Hepatol 1998; 28:165.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/78\" class=\"nounderline abstract_t\">Neff GW, Reddy KR, Durazo FA, et al. Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid. J Hepatol 2004; 41:1062.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/79\" class=\"nounderline abstract_t\">Bajaj J, Knox JF, Komorowski R, Saeian K. The irony of herbal hepatitis: Ma-Huang-induced hepatotoxicity associated with compound heterozygosity for hereditary hemochromatosis. Dig Dis Sci 2003; 48:1925.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/80\" class=\"nounderline abstract_t\">Nadir A, Agrawal S, King PD, Marshall JB. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am J Gastroenterol 1996; 91:1436.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/81\" class=\"nounderline abstract_t\">Lekehal M, Pessayre D, Lereau JM, et al. Hepatotoxicity of the herbal medicine germander: metabolic activation of its furano diterpenoids by cytochrome P450 3A Depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology 1996; 24:212.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/82\" class=\"nounderline abstract_t\">Lalibert&eacute; L, Villeneuve JP. Hepatitis after the use of germander, a herbal remedy. CMAJ 1996; 154:1689.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/83\" class=\"nounderline abstract_t\">Mostefa-Kara N, Pauwels A, Pines E, et al. Fatal hepatitis after herbal tea. Lancet 1992; 340:674.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/84\" class=\"nounderline abstract_t\">Castot A, Larrey D. [Hepatitis observed during a treatment with a drug or tea containing Wild Germander. Evaluation of 26 cases reported to the Regional Centers of Pharmacovigilance]. Gastroenterol Clin Biol 1992; 16:916.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/85\" class=\"nounderline abstract_t\">Castot A, Djezzar S, Deleau N, et al. [Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants]. Therapie 1997; 52:97.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/86\" class=\"nounderline abstract_t\">Mimidis KP, Papadopoulos VP, Baltatzidis G, et al. Severe acute cholestasis caused by Teucrium polium. J Gastrointestin Liver Dis 2009; 18:387.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/87\" class=\"nounderline abstract_t\">MacGregor FB, Abernethy VE, Dahabra S, et al. Hepatotoxicity of herbal remedies. BMJ 1989; 299:1156.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/88\" class=\"nounderline abstract_t\">Harvey J, Colin-Jones DG. Mistletoe hepatitis. Br Med J (Clin Res Ed) 1981; 282:186.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/89\" class=\"nounderline abstract_t\">Hullar TE, Sapers BL, Ridker PM, et al. Herbal toxicity and fatal hepatic failure. Am J Med 1999; 106:267.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/90\" class=\"nounderline abstract_t\">Sheikh NM, Philen RM, Love LA. Chaparral-associated hepatotoxicity. Arch Intern Med 1997; 157:913.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/91\" class=\"nounderline abstract_t\">Katz M, Saibil F. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J Clin Gastroenterol 1990; 12:203.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/92\" class=\"nounderline abstract_t\">Gordon DW, Rosenthal G, Hart J, et al. Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications. JAMA 1995; 273:489.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/93\" class=\"nounderline abstract_t\">Smith BC, Desmond PV. Acute hepatitis induced by ingestion of the herbal medication chaparral. Aust N Z J Med 1993; 23:526.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/94\" class=\"nounderline abstract_t\">Batchelor WB, Heathcote J, Wanless IR. Chaparral-induced hepatic injury. Am J Gastroenterol 1995; 90:831.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/95\" class=\"nounderline abstract_t\">Bach N, Thung SN, Schaffner F. Comfrey herb tea-induced hepatic veno-occlusive disease. Am J Med 1989; 87:97.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/96\" class=\"nounderline abstract_t\">Ridker PM, McDermott WV. Comfrey herb tea and hepatic veno-occlusive disease. Lancet 1989; 1:657.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/97\" class=\"nounderline abstract_t\">Weston CF, Cooper BT, Davies JD, Levine DF. Veno-occlusive disease of the liver secondary to ingestion of comfrey. Br Med J (Clin Res Ed) 1987; 295:183.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/98\" class=\"nounderline abstract_t\">Yeong ML, Swinburn B, Kennedy M, Nicholson G. Hepatic veno-occlusive disease associated with comfrey ingestion. J Gastroenterol Hepatol 1990; 5:211.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/99\" class=\"nounderline abstract_t\">Stickel F, Seitz HK. The efficacy and safety of comfrey. Public Health Nutr 2000; 3:501.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/100\" class=\"nounderline abstract_t\">Kumana CR, Ng M, Lin HJ, et al. Herbal tea induced hepatic veno-occlusive disease: quantification of toxic alkaloid exposure in adults. Gut 1985; 26:101.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/101\" class=\"nounderline abstract_t\">Smith LW, Culvenor CC. Plant sources of hepatotoxic pyrrolizidine alkaloids. J Nat Prod 1981; 44:129.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/102\" class=\"nounderline abstract_t\">Mattocks AR. Toxicity of pyrrolizidine alkaloids. Nature 1968; 217:723.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/103\" class=\"nounderline abstract_t\">Gordon WP, Forte AJ, McMurtry RJ, et al. Hepatotoxicity and pulmonary toxicity of pennyroyal oil and its constituent terpenes in the mouse. Toxicol Appl Pharmacol 1982; 65:413.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/104\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Hepatic toxicity possibly associated with kava-containing products--United States, Germany, and Switzerland, 1999-2002. MMWR Morb Mortal Wkly Rep 2002; 51:1065.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/105\" class=\"nounderline abstract_t\">Ernst E. Safety concerns about kava. Lancet 2002; 359:1865.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/106\" class=\"nounderline abstract_t\">Wooltorton E. Herbal kava: reports of liver toxicity. CMAJ 2002; 166:777.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/107\" class=\"nounderline abstract_t\">Campo JV, McNabb J, Perel JM, et al. Kava-induced fulminant hepatic failure. J Am Acad Child Adolesc Psychiatry 2002; 41:631.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/108\" class=\"nounderline abstract_t\">Gow PJ, Connelly NJ, Hill RL, et al. Fatal fulminant hepatic failure induced by a natural therapy containing kava. Med J Aust 2003; 178:442.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/109\" class=\"nounderline abstract_t\">Yoshida EM, McLean CA, Cheng ES, et al. Chinese herbal medicine, fulminant hepatitis, and liver transplantation. Am J Gastroenterol 1996; 91:2647.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/110\" class=\"nounderline abstract_t\">Roeder E. Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie 2000; 55:711.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/111\" class=\"nounderline abstract_t\">Li N, Xia Q, Ruan J, et al. Hepatotoxicity and tumorigenicity induced by metabolic activation of pyrrolizidine alkaloids in herbs. Curr Drug Metab 2011; 12:823.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/112\" class=\"nounderline abstract_t\">Guzman G, Kallwitz ER, Wojewoda C, et al. Liver Injury with Features Mimicking Autoimmune Hepatitis following the Use of Black Cohosh. Case Rep Med 2009; 2009:918156.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/113\" class=\"nounderline abstract_t\">Pearson W. Pyrrolizidine alkaloids in higher plants: hepatic veno-occlusive disease associated with chronic consumption. J Neutraceuticals 2000; 3:87.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/114\" class=\"nounderline abstract_t\">Benninger J, Schneider HT, Schuppan D, et al. Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology 1999; 117:1234.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/115\" class=\"nounderline abstract_t\">Xia Q, Zhao Y, Lin G, et al. Pyrrolizidine Alkaloid-Protein Adducts: Potential Non-invasive Biomarkers of Pyrrolizidine Alkaloid-Induced Liver Toxicity and Exposure. Chem Res Toxicol 2016; 29:1282.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/116\" class=\"nounderline abstract_t\">Steenkamp V, Stewart MJ, Zuckerman M. Clinical and analytical aspects of pyrrolizidine poisoning caused by South African traditional medicines. Ther Drug Monit 2000; 22:302.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/117\" class=\"nounderline abstract_t\">Tandon HD, Tandon BN, Ramalingaswami V. Epidemic of toxic hepatitis in India of possible mycotoxic origin. Arch Pathol Lab Med 1978; 102:372.</a></li><li class=\"breakAll\">FDA advises dietary supplement manufacturers to remove comfrey products from the market http://www.fda.gov/Food/DietarySupplements/Alerts/ucm111219.htm (Accessed on August 03, 2016).</li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/119\" class=\"nounderline abstract_t\">Conradie J, Stewart MJ, Steenkamp V. GC/MS identification of toxic pyrrolizidine alkaloids in traditional remedies given to two sets of twins. Ann Clin Biochem 2005; 42:141.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/120\" class=\"nounderline abstract_t\">Gao H, Li N, Wang JY, et al. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids. J Dig Dis 2012; 13:33.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/121\" class=\"nounderline abstract_t\">Neuman MG, Jia AY, Steenkamp V. Senecio latifolius induces in vitro hepatocytotoxicity in a human cell line. Can J Physiol Pharmacol 2007; 85:1063.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/122\" class=\"nounderline abstract_t\">Ji LL, Zhang M, Sheng YC, Wang ZT. Pyrrolizidine alkaloid clivorine induces apoptosis in human normal liver L-02 cells and reduces the expression of p53 protein. Toxicol In Vitro 2005; 19:41.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/123\" class=\"nounderline abstract_t\">Valla D, Benhamou JP. Drug-induced vascular and sinusoidal lesions of the liver. Baillieres Clin Gastroenterol 1988; 2:481.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/124\" class=\"nounderline abstract_t\">Schiano TD. Liver injury from herbs and other botanicals. Clin Liver Dis 1988; 607.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/125\" class=\"nounderline abstract_t\">Schiano TD. Liver injury from herbs and other botanicals. Clin Liver Dis 1998; 2:607.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/126\" class=\"nounderline abstract_t\">Ridker PM, Ohkuma S, McDermott WV, et al. Hepatic venocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. Gastroenterology 1985; 88:1050.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/127\" class=\"nounderline abstract_t\">Neuman MG, Cohen L, Opris M, et al. Hepatotoxicity of Pyrrolizidine Alkaloids. J Pharm Pharm Sci 2015; 18:825.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/128\" class=\"nounderline abstract_t\">E Roeder, H Wiedenfeld. Plants containing pyrrolizidine alkaloids used in the traditional Indian medicine-including Ayurveda. Pharmazie 2013; 68:83.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/129\" class=\"nounderline abstract_t\">Wai CT, Tan BH, Chan CL, et al. Drug-induced liver injury at an Asian center: a prospective study. Liver Int 2007; 27:465.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/130\" class=\"nounderline abstract_t\">E Roeder, H Wiedenfeld. Plants containing pyrrolizidine alkaloids used in the traditional Indian medicine-included Ayurveda. Pharmazie 2013; 68:83.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/131\" class=\"nounderline abstract_t\">Ernst E. Heavy metals in traditional Indian remedies. Eur J Clin Pharmacol 2002; 57:891.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/132\" class=\"nounderline abstract_t\">Bateman J, Chapman RD, Simpson D. Possible toxicity of herbal remedies. Scott Med J 1998; 43:7.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/133\" class=\"nounderline abstract_t\">Farrell GC. Drug-induced hepatic injury. J Gastroenterol Hepatol 1997; 12:S242.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/134\" class=\"nounderline abstract_t\">Fau D, Lekehal M, Farrell G, et al. Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology 1997; 113:1334.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/135\" class=\"nounderline abstract_t\">Matt&eacute;i A, Rucay P, Samuel D, et al. Liver transplantation for severe acute liver failure after herbal medicine (Teucrium polium) administration. J Hepatol 1995; 22:597.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/136\" class=\"nounderline abstract_t\">Savvidou S, Goulis J, Giavazis I, et al. Herb-induced hepatitis by Teucrium polium L.: report of two cases and review of the literature. Eur J Gastroenterol Hepatol 2007; 19:507.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/137\" class=\"nounderline abstract_t\">Dourakis SP, Papanikolaou IS, Tzemanakis EN, Hadziyannis SJ. Acute hepatitis associated with herb (Teucrium capitatum L.) administration. Eur J Gastroenterol Hepatol 2002; 14:693.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/138\" class=\"nounderline abstract_t\">Poon WT, Chau TL, Lai CK, et al. Hepatitis induced by Teucrium viscidum. Clin Toxicol (Phila) 2008; 46:819.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/139\" class=\"nounderline abstract_t\">Vahlensieck U, Hahn R, Winterhoff H, et al. The effect of Chelidonium majus herb extract on choleresis in the isolated perfused rat liver. Planta Med 1995; 61:267.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/140\" class=\"nounderline abstract_t\">Moro PA, Cassetti F, Giugliano G, et al. Hepatitis from Greater celandine (Chelidonium majus L.): review of literature and report of a new case. J Ethnopharmacol 2009; 124:328.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/141\" class=\"nounderline abstract_t\">Stickel F, P&ouml;schl G, Seitz HK, et al. Acute hepatitis induced by Greater Celandine (Chelidonium majus). Scand J Gastroenterol 2003; 38:565.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/142\" class=\"nounderline abstract_t\">Crijns AP, de Smet PA, van den Heuvel M, et al. [Acute hepatitis after use of a herbal preparation with greater celandine (Chelidonium majus)]. Ned Tijdschr Geneeskd 2002; 146:124.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/143\" class=\"nounderline abstract_t\">De Smet PA. Safety concerns about kava not unique. Lancet 2002; 360:1336.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/144\" class=\"nounderline abstract_t\">Greving I, Meister V, Monnerjahn C, et al. Chelidonium majus: a rare reason for severe hepatotoxic reaction. Pharmacoepidemiol Drug Saf 1998; 7 Suppl 1:S66.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/145\" class=\"nounderline abstract_t\">Rifai K, Flemming P, Manns MP, Trautwein C. [Severe drug hepatitis caused by Chelidonium]. Internist (Berl) 2006; 47:749.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/146\" class=\"nounderline abstract_t\">Teschke R, Glass X, Schulze J, Eickhoff A. Suspected Greater Celandine hepatotoxicity: liver-specific causality evaluation of published case reports from Europe. Eur J Gastroenterol Hepatol 2012; 24:270.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/147\" class=\"nounderline abstract_t\">Teschke R, Frenzel C, Glass X, et al. Greater Celandine hepatotoxicity: a clinical review. Ann Hepatol 2012; 11:838.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/148\" class=\"nounderline abstract_t\">Teschke R, Glass X, Schulze J. Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): causality assessment of 22 spontaneous reports. Regul Toxicol Pharmacol 2011; 61:282.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/149\" class=\"nounderline abstract_t\">Kassler WJ, Blanc P, Greenblatt R. The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch Intern Med 1991; 151:2281.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/150\" class=\"nounderline abstract_t\">Kauma H, Koskela R, M&auml;kisalo H, et al. Toxic acute hepatitis and hepatic fibrosis after consumption of chaparral tablets. Scand J Gastroenterol 2004; 39:1168.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/151\" class=\"nounderline abstract_t\">Drecktrah D, de Figueiredo P, Mason RM, Brown WJ. Retrograde trafficking of both Golgi complex and TGN markers to the ER induced by nordihydroguaiaretic acid and cyclofenil diphenol. J Cell Sci 1998; 111 ( Pt 7):951.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/152\" class=\"nounderline abstract_t\">Zaim N, Guemouri L, Lamnaouer D, Benjouad A. [Study of four cases of poisoning by Atractylis gummifera L. in Morocco]. Therapie 2008; 63:49.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/153\" class=\"nounderline abstract_t\">Ahid S, El Cadi MA, Meddah B, Cherrah Y. [Atractylis gummifera: from poisoning to the analytic methods]. Ann Biol Clin (Paris) 2012; 70:263.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/154\" class=\"nounderline abstract_t\">Daniele C, Dahamna S, Firuzi O, et al. Atractylis gummifera L. poisoning: an ethnopharmacological review. J Ethnopharmacol 2005; 97:175.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/155\" class=\"nounderline abstract_t\">Hamouda C, H&eacute;dhili A, Ben Salah N, et al. A review of acute poisoning from Atractylis gummifera L. Vet Hum Toxicol 2004; 46:144.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/156\" class=\"nounderline abstract_t\">Popat A, Shear NH, Malkiewicz I, et al. The toxicity of Callilepis laureola, a South African traditional herbal medicine. Clin Biochem 2001; 34:229.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/157\" class=\"nounderline abstract_t\">Stewart MJ, Steenkamp V, van der Merwe S, et al. The cytotoxic effects of a traditional Zulu remedy, impila (Callilepis laureola). Hum Exp Toxicol 2002; 21:643.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/158\" class=\"nounderline abstract_t\">Anderson IB, Mullen WH, Meeker JE, et al. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med 1996; 124:726.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/159\" class=\"nounderline abstract_t\">Bakerink JA, Gospe SM Jr, Dimand RJ, Eldridge MW. Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Pediatrics 1996; 98:944.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/160\" class=\"nounderline abstract_t\">Thomassen D, Slattery JT, Nelson SD. Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione. J Pharmacol Exp Ther 1990; 253:567.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/161\" class=\"nounderline abstract_t\">Stickel F, Baum&uuml;ller HM, Seitz K, et al. Hepatitis induced by Kava (Piper methysticum rhizoma). J Hepatol 2003; 39:62.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/162\" class=\"nounderline abstract_t\">Teschke R. Kava hepatotoxicity--a clinical review. Ann Hepatol 2010; 9:251.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/163\" class=\"nounderline abstract_t\">Teschke R, Schwarzenboeck A, Hennermann KH. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol 2008; 20:1182.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/164\" class=\"nounderline abstract_t\">Teschke R. Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver Int 2010; 30:1270.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/165\" class=\"nounderline abstract_t\">Teschke R, Qiu SX, Lebot V. Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits. Dig Liver Dis 2011; 43:676.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/166\" class=\"nounderline abstract_t\">Sarris J, Kavanagh DJ, Byrne G, et al. The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology (Berl) 2009; 205:399.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/167\" class=\"nounderline abstract_t\">Teschke R, Genthner A, Wolff A. Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures. J Ethnopharmacol 2009; 123:378.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/168\" class=\"nounderline abstract_t\">Javaid A, Bonkovsky HL. Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern. J Hepatol 2006; 45:334.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/169\" class=\"nounderline abstract_t\">Bonkovsky HL. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann Intern Med 2006; 144:68.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/170\" class=\"nounderline abstract_t\">Molinari M, Watt KD, Kruszyna T, et al. Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl 2006; 12:1892.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/171\" class=\"nounderline abstract_t\">Galati G, Lin A, Sultan AM, O'Brien PJ. Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radic Biol Med 2006; 40:570.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/172\" class=\"nounderline abstract_t\">Weinstein DH, Twaddell WS, Raufman JP, et al. SlimQuick&trade; - associated hepatotoxicity in a woman with alpha-1 antitrypsin heterozygosity. World J Hepatol 2012; 4:154.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/173\" class=\"nounderline abstract_t\">Mazzanti G, Menniti-Ippolito F, Moro PA, et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 2009; 65:331.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/174\" class=\"nounderline abstract_t\">Ishak KG. Hepatic lesions caused by anabolic and contraceptive steroids. Semin Liver Dis 1981; 1:116.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/175\" class=\"nounderline abstract_t\">Hepatic effects of 17 alpha-alkylated anaboli-androgenic steroids. HIV Hotline 1998; 8:2.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/176\" class=\"nounderline abstract_t\">Kafrouni MI, Anders RA, Verma S. Hepatotoxicity associated with dietary supplements containing anabolic steroids. Clin Gastroenterol Hepatol 2007; 5:809.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/177\" class=\"nounderline abstract_t\">Timcheh-Hariri A, Balali-Mood M, Aryan E, et al. Toxic hepatitis in a group of 20 male body-builders taking dietary supplements. Food Chem Toxicol 2012; 50:3826.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/178\" class=\"nounderline abstract_t\">Martin DJ, Partridge BJ, Shields W. Hepatotoxicity associated with the dietary supplement N.O.-XPLODE. Ann Intern Med 2013; 159:503.</a></li><li class=\"breakAll\">Food and Drug Administration. Body Building Products Marketed as Containing Steroids or Steroid-Like Substances http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm173965.htm (Accessed on August 03, 2016).</li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/180\" class=\"nounderline abstract_t\">Pierard S, Coche JC, Lanthier P, et al. Severe hepatitis associated with the use of black cohosh: a report of two cases and an advice for caution. Eur J Gastroenterol Hepatol 2009; 21:941.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/181\" class=\"nounderline abstract_t\">Mahady GB, Low Dog T, Barrett ML, et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008; 15:628.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/182\" class=\"nounderline abstract_t\">Cohen SM, O'Connor AM, Hart J, et al. Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause 2004; 11:575.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/183\" class=\"nounderline abstract_t\">Levitsky J, Alli TA, Wisecarver J, Sorrell MF. Fulminant liver failure associated with the use of black cohosh. Dig Dis Sci 2005; 50:538.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/184\" class=\"nounderline abstract_t\">Lynch CR, Folkers ME, Hutson WR. Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver Transpl 2006; 12:989.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/185\" class=\"nounderline abstract_t\">ET Enbom, MD Le, L Oestrich, et al.. Mechanism of hepatotoxicity due to black cohosh: (Cimicifuga racemose): historical, immunohistorical and electron microscopy analysis of two liver biopsies with clinical correlation. Exp Mol Pathol 2014; 96:279.</a></li><li class=\"breakAll\">https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm586111.htm (Accessed on November 21, 2017).</li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/187\" class=\"nounderline abstract_t\">Chalasani N, Vuppalanchi R, Navarro V, et al. Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series. Ann Intern Med 2012; 156:857.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/188\" class=\"nounderline abstract_t\">Wang ZG, Ren J. Current status and future direction of Chinese herbal medicine. Trends Pharmacol Sci 2002; 23:347.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/189\" class=\"nounderline abstract_t\">Perharic-Walton L, Murray V. Toxicity of Chinese herbal remedies. Lancet 1992; 340:674.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/190\" class=\"nounderline abstract_t\">Graham-Brown R. Toxicity of Chinese herbal remedies. Lancet 1992; 340:673.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/191\" class=\"nounderline abstract_t\">Jung KA, Min HJ, Yoo SS, et al. Drug-Induced Liver Injury: Twenty Five Cases of Acute Hepatitis Following Ingestion of Polygonum multiflorum Thunb. Gut Liver 2011; 5:493.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/192\" class=\"nounderline abstract_t\">Horowitz RS, Feldhaus K, Dart RC, et al. The clinical spectrum of Jin Bu Huan toxicity. Arch Intern Med 1996; 156:899.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/193\" class=\"nounderline abstract_t\">Borum ML. Fulminant exacerbation of autoimmune hepatitis after the use of ma huang. Am J Gastroenterol 2001; 96:1654.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/194\" class=\"nounderline abstract_t\">Skoulidis F, Alexander GJ, Davies SE. Ma huang associated acute liver failure requiring liver transplantation. Eur J Gastroenterol Hepatol 2005; 17:581.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/195\" class=\"nounderline abstract_t\">Verma S, Thuluvath PJ. Complementary and alternative medicine in hepatology: review of the evidence of efficacy. Clin Gastroenterol Hepatol 2007; 5:408.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/196\" class=\"nounderline abstract_t\">Itoh S, Marutani K, Nishijima T, et al. Liver injuries induced by herbal medicine, syo-saiko-to (xiao-chai-hu-tang). Dig Dis Sci 1995; 40:1845.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/197\" class=\"nounderline abstract_t\">Kamiyama T, Nouchi T, Kojima S, et al. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 1997; 92:703.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/198\" class=\"nounderline abstract_t\">Hsu LM, Huang YS, Tsay SH, et al. Acute hepatitis induced by Chinese hepatoprotective herb, xiao-chai-hu-tang. J Chin Med Assoc 2006; 69:86.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/199\" class=\"nounderline abstract_t\">Adachi M, Saito H, Kobayashi H, et al. Hepatic injury in 12 patients taking the herbal weight loss AIDS Chaso or Onshido. Ann Intern Med 2003; 139:488.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/200\" class=\"nounderline abstract_t\">Stevens T, Qadri A, Zein NN. Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut. Ann Intern Med 2005; 142:477.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/201\" class=\"nounderline abstract_t\">Jones FJ, Andrews AH. Acute liver injury associated with the herbal supplement hydroxycut in a soldier deployed to Iraq. Am J Gastroenterol 2007; 102:2357.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/202\" class=\"nounderline abstract_t\">Dara L, Hewett J, Lim JK. Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements. World J Gastroenterol 2008; 14:6999.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/203\" class=\"nounderline abstract_t\">Shim M, Saab S. Severe hepatotoxicity due to Hydroxycut: a case report. Dig Dis Sci 2009; 54:406.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/204\" class=\"nounderline abstract_t\">Fong TL, Klontz KC, Canas-Coto A, et al. Hepatotoxicity due to hydroxycut: a case series. Am J Gastroenterol 2010; 105:1561.</a></li><li class=\"breakAll\">US Food and Drug Administration. Warning on Hydroxycut products http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm152152.htm (Accessed on August 03, 2016).</li><li class=\"breakAll\">US Food and Drug Administration. FDA Warns Consumers to Stop Using Hydroxycut Products http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149575.htm (Accessed on August 03, 2016).</li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/207\" class=\"nounderline abstract_t\">Schoepfer AM, Engel A, Fattinger K, et al. Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J Hepatol 2007; 47:521.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/208\" class=\"nounderline abstract_t\">Elinav E, Pinsker G, Safadi R, et al. Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. J Hepatol 2007; 47:514.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/209\" class=\"nounderline abstract_t\">Duque JM, Ferreiro J, Salgueiro E, Manso G. [Hepatotoxicity associated with the consumption of herbal slimming products]. Med Clin (Barc) 2007; 128:238.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/210\" class=\"nounderline abstract_t\">Chao S, Anders M, Turbay M, et al. [Toxic hepatitis by consumption Herbalife products a case report]. Acta Gastroenterol Latinoam 2008; 38:274.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/211\" class=\"nounderline abstract_t\">Manso G, L&oacute;pez-Rivas L, Duque JM, Salgueiro E. Spanish reports of hepatotoxicity associated with Herbalife products. J Hepatol 2008; 49:289.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/212\" class=\"nounderline abstract_t\">Manso G, L&oacute;pez-Rivas L, Salgueiro ME, et al. Continuous reporting of new cases in Spain supports the relationship between Herbalife&reg; products and liver injury. Pharmacoepidemiol Drug Saf 2011; 20:1080.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/213\" class=\"nounderline abstract_t\">Ramanathan VS, Mitropoulos E, Shlopov B, et al. An Enzyte'ing' case of acute hepatitis. J Clin Gastroenterol 2011; 45:834.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/214\" class=\"nounderline abstract_t\">Chatham-Stephens K, Taylor E, Chang A, et al. Hepatotoxicity associated with weight loss or sports dietary supplements, including OxyELITE Pro&trade; - United States, 2013. Drug Test Anal 2017; 9:68.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/215\" class=\"nounderline abstract_t\">Stickel F, Kessebohm K, Weimann R, Seitz HK. Review of liver injury associated with dietary supplements. Liver Int 2011; 31:595.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/216\" class=\"nounderline abstract_t\">Pacheco A, Gonz&aacute;lez-Sainz J, Arocena C, et al. Community acquired pneumonia caused by Chlamydia pneumoniae strain TWAR in chronic cardiopulmonary disease in the elderly. Respiration 1991; 58:316.</a></li><li class=\"breakAll\">http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm152152.htm (Accessed on July 10, 2012).</li><li class=\"breakAll\">http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149575.htm (Accessed on July 10, 2012).</li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/219\" class=\"nounderline abstract_t\">Roytman MM, P&ouml;rzgen P, Lee CL, et al. Outbreak of severe hepatitis linked to weight-loss supplement OxyELITE Pro. Am J Gastroenterol 2014; 109:1296.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/220\" class=\"nounderline abstract_t\">Foley S, Butlin E, Shields W, Lacey B. Experience with OxyELITE pro and acute liver injury in active duty service members. Dig Dis Sci 2014; 59:3117.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/221\" class=\"nounderline abstract_t\">Klontz KC, DeBeck HJ, LeBlanc P, et al. The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement. Public Health Rep 2015; 130:526.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/222\" class=\"nounderline abstract_t\">Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998; 158:2200.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/223\" class=\"nounderline abstract_t\">Perron AD, Patterson JA, Yanofsky NN. Kombucha &quot;mushroom&quot; hepatotoxicity. Ann Emerg Med 1995; 26:660.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/224\" class=\"nounderline abstract_t\">Favreau JT, Ryu ML, Braunstein G, et al. Severe hepatotoxicity associated with the dietary supplement LipoKinetix. Ann Intern Med 2002; 136:590.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/225\" class=\"nounderline abstract_t\">Nadir A, Reddy D, Van Thiel DH. Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity. Am J Gastroenterol 2000; 95:3634.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/226\" class=\"nounderline abstract_t\">Kao WF, Hung DZ, Tsai WJ, et al. Podophyllotoxin intoxication: toxic effect of Bajiaolian in herbal therapeutics. Hum Exp Toxicol 1992; 11:480.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/227\" class=\"nounderline abstract_t\">Uc A, Bishop WP, Sanders KD. Camphor hepatotoxicity. South Med J 2000; 93:596.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/228\" class=\"nounderline abstract_t\">Mallat A, Dhumeaux D. Cocaine and the liver. J Hepatol 1991; 12:275.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/229\" class=\"nounderline abstract_t\">Wurtz AS, Vial T, Isoard B, Saillard E. Possible hepatotoxicity from Copaltra, an herbal medicine. Ann Pharmacother 2002; 36:941.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/230\" class=\"nounderline abstract_t\">Millonig G, Stadlmann S, Vogel W. Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia). Eur J Gastroenterol Hepatol 2005; 17:445.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/231\" class=\"nounderline abstract_t\">Jorge OA, Jorge AD. Hepatotoxicity associated with the ingestion of Centella asiatica. Rev Esp Enferm Dig 2005; 97:115.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/232\" class=\"nounderline abstract_t\">Beuers U, Spengler U, Pape GR. Hepatitis after chronic abuse of senna. Lancet 1991; 337:372.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatotoxicity-due-to-herbal-medications-and-dietary-supplements/abstract/233\" class=\"nounderline abstract_t\">Yang HN, Kim DJ, Kim YM, et al. Aloe-induced toxic hepatitis. J Korean Med Sci 2010; 25:492.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3618 Version 25.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H24\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H2947492025\" id=\"outline-link-H2947492025\">INTRODUCTION</a></li><li><a href=\"#H2926900639\" id=\"outline-link-H2926900639\">DATABASE OF DRUGS, HERBS, AND SUPPLEMENTS ASSOCIATED WITH HEPATOTOXICITY</a></li><li><a href=\"#H122810330\" id=\"outline-link-H122810330\">REGULATION</a></li><li><a href=\"#H2532524339\" id=\"outline-link-H2532524339\">FREQUENCY OF HEPATOTOXICITY</a></li><li><a href=\"#H3762083709\" id=\"outline-link-H3762083709\">DIAGNOSIS</a></li><li><a href=\"#H734050788\" id=\"outline-link-H734050788\">TREATMENT</a></li><li><a href=\"#H2358833283\" id=\"outline-link-H2358833283\">SPECIFIC HEPATOTOXIC HERBS</a><ul><li><a href=\"#H2569065065\" id=\"outline-link-H2569065065\">Pyrrolizidine alkaloids</a></li><li><a href=\"#H1441342082\" id=\"outline-link-H1441342082\">Ayurvedic herbs</a></li><li><a href=\"#H3263091012\" id=\"outline-link-H3263091012\">Germander</a></li><li><a href=\"#H1139068093\" id=\"outline-link-H1139068093\">Greater celandine</a></li><li><a href=\"#H792097579\" id=\"outline-link-H792097579\">Chaparral</a></li><li><a href=\"#H1716929119\" id=\"outline-link-H1716929119\">Atractylis gummifera and callilepis laureola</a></li><li><a href=\"#H2510559153\" id=\"outline-link-H2510559153\">Pennyroyal</a></li><li><a href=\"#H4009848262\" id=\"outline-link-H4009848262\">Mistletoe</a></li><li><a href=\"#H30074381\" id=\"outline-link-H30074381\">Kava kava</a></li><li><a href=\"#H2923594748\" id=\"outline-link-H2923594748\">Green tea extracts</a></li><li><a href=\"#H668755844\" id=\"outline-link-H668755844\">Androgenic anabolic steroids</a></li><li><a href=\"#H1353834277\" id=\"outline-link-H1353834277\">Black cohosh</a></li><li><a href=\"#H1537314118\" id=\"outline-link-H1537314118\">Flavocoxid</a></li></ul></li><li><a href=\"#H2414263929\" id=\"outline-link-H2414263929\">CHINESE HERBAL REMEDIES</a><ul><li><a href=\"#H2587798319\" id=\"outline-link-H2587798319\">Jin Bu Huan</a></li><li><a href=\"#H2774112036\" id=\"outline-link-H2774112036\">Ma-Huang (ephedra)</a></li><li><a href=\"#H273521750\" id=\"outline-link-H273521750\">Syo-saiko-to</a></li><li><a href=\"#H3408867466\" id=\"outline-link-H3408867466\">Chaso or Onshido</a></li></ul></li><li><a href=\"#H3842336760\" id=\"outline-link-H3842336760\">WEIGHT LOSS PRODUCTS</a><ul><li><a href=\"#H1293012867\" id=\"outline-link-H1293012867\">Herbalife products</a></li><li><a href=\"#H3552017098\" id=\"outline-link-H3552017098\">Hydroxycut</a></li><li><a href=\"#H530693390\" id=\"outline-link-H530693390\">OxyELITE Pro</a></li></ul></li><li><a href=\"#H1150564995\" id=\"outline-link-H1150564995\">OTHER HEPATOTOXIC HERBS</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H1656331258\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H24\" id=\"outline-link-H24\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"GAST/3618|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/72867\" class=\"graphic graphic_table\">- Complementary therapies</a></li><li><a href=\"image.htm?imageKey=GAST/76892\" class=\"graphic graphic_table\">- Classification of liver test abnormalities</a></li><li><a href=\"image.htm?imageKey=GAST/55524\" class=\"graphic graphic_table\">- Drug reactions RUCAM</a></li><li><a href=\"image.htm?imageKey=GAST/76400\" class=\"graphic graphic_table\">- Herbal medicine hepatotoxicity</a></li><li><a href=\"image.htm?imageKey=GAST/61224\" class=\"graphic graphic_table\">- Pyrrolizidine alkaloids</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-liver-failure-in-adults-etiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=autoimmune-hepatitis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Autoimmune hepatitis: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-hepatic-sinusoidal-obstruction-syndrome-veno-occlusive-disease-following-hematopoietic-cell-transplantation\" class=\"medical medical_review\">Diagnosis of hepatic sinusoidal obstruction syndrome (veno-occlusive disease) following hematopoietic cell transplantation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drug-reaction-with-eosinophilia-and-systemic-symptoms-dress\" class=\"medical medical_review\">Drug reaction with eosinophilia and systemic symptoms (DRESS)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drug-induced-liver-injury\" class=\"medical medical_review\">Drug-induced liver injury</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-herbal-medicine-and-dietary-supplements\" class=\"medical medical_review\">Overview of herbal medicine and dietary supplements</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=toxic-hepatitis-the-basics\" class=\"medical medical_basics\">Patient education: Toxic hepatitis (The Basics)</a></li></ul></div></div>","javascript":null}